{"text": "This group was excluded from the study as they were deemed not compliant to the treatment .12 patients that were planned to receive postoperative RT or CRT had metastasis or a second primary cancer during or prior to starting adjuvant therapies .", "label": "", "metadata": {}, "score": "28.761314"}
{"text": "Patients receiving S - RT were 3.6 times more likely to develop metastasis compared to S - CRT .These findings concur with the RTOG and EORTC trials in that the addition of chemotherapy to adjuvant RT improves distant metastatic control [ 3 , 4 ] .", "label": "", "metadata": {}, "score": "33.429337"}
{"text": "Data examining preoperative ChT alone for resectable gastric cancer show pCR rates of only 0 - 7 % [ 2 , 32 , 33 ] , suggesting that the addition of RT with concurrent ChT may improve tumor response and disease - related endpoints compared to a ChT alone approach .", "label": "", "metadata": {}, "score": "34.165154"}
{"text": "The basis of adding concurrent chemotherapy to adjuvant RT is that advanced tumors respond better to concurrent CRT rather than to RT alone [ 10 - 14 ] .", "label": "", "metadata": {}, "score": "34.238995"}
{"text": "Patients differed in their site of initial relapse with 30.9 % of patients receiving RT only presenting with distant relapse compared to 10 % in the CRT arm .", "label": "", "metadata": {}, "score": "35.41654"}
{"text": "Patients differed in their site of initial relapse with 30.9 % of patients receiving RT only presenting with distant relapse compared to 10 % in the CRT arm .", "label": "", "metadata": {}, "score": "35.41654"}
{"text": "The R0 resection rate for those undergoing surgery in our series ( 86 % ) is comparable to prospective studies utilizing neoadjuvant CRT for gastric cancer [ 12 - 14 , 24 ] .", "label": "", "metadata": {}, "score": "35.587196"}
{"text": "There have been several studies documenting the efficacy of chemoradiation over radiation alone in the treatment of locally advanced cervical cancer .One of these studies , published in the NEJM in 1999 , was RTOG 90 - 01 , which randomized patients between para - aortic ( PA ) node + pelvic radiation vs. chemotherapy + pelvic radiation .", "label": "", "metadata": {}, "score": "35.69294"}
{"text": "The results of this study support the RTOG and EORTC landmark trials .The addition of postoperative chemotherapy to S - RT for advanced OCSCC appears to improve overall survival by 22 % and 18 % at 2 and 5 years post - treatment , respectively .", "label": "", "metadata": {}, "score": "35.866684"}
{"text": "This chemotherapy was repeated q 3 weeks x 3 .90 % had squamous cell cancer .Patients were stratified by FIGO stage ( IB - IIB vs. III - IVa ) .", "label": "", "metadata": {}, "score": "36.766075"}
{"text": "This chemotherapy was repeated q 3 weeks x 3 .90 % had squamous cell cancer .Patients were stratified by FIGO stage ( IB - IIB vs. III - IVa ) .", "label": "", "metadata": {}, "score": "36.766075"}
{"text": "As a result , induction chemotherapy is currently not indicated .Adjuvant chemotherapy was evaluated in 3 randomized trials ; there was no benefit .Phase II RTOG 81 - 17 demonstrated the feasibility of concurrent cisplatin with RT in advanced H&N cancers ; it included 22 % NPC .", "label": "", "metadata": {}, "score": "37.05047"}
{"text": "Doses for curative RT ranged from 6300 to 8000 Gy and for adjuvant RT from 5500 to 7000 GY .Cisplatin or carboplatin based CRT protocols were used exclusively for all patients .", "label": "", "metadata": {}, "score": "37.5357"}
{"text": "Overall response rate was not statistically significant between the 2 groups .Patients with squamous cell carcinoma histology had a slightly better overall response rate to definitive chemoradiation ( 66.9 % vs. 57.6 % in adenocarcinoma ) and consolidation chemotherapy ( 42.9 % vs. 33.3 % in adenocarcinoma ) .", "label": "", "metadata": {}, "score": "37.781853"}
{"text": "Materials and Methods .403 patients were entered into this prospective , randomized study .Patients in the RT alone group ( RT ) were treated with whole pelvis radiation with extension of a \" chimney \" field to the bottom of L1 to treat the PA nodes .", "label": "", "metadata": {}, "score": "38.010525"}
{"text": "37 patients on this arm did not receive any adjuvant therapy .90 % of all patients received at least 70 Gy of RT .Overall , a higher rate of mucositis , anorexia , neutropenia , and thrombocytopenia was seen on the CRT arm ( Arm 2 ) .", "label": "", "metadata": {}, "score": "38.05922"}
{"text": "37 patients on this arm did not receive any adjuvant therapy .90 % of all patients received at least 70 Gy of RT .Overall , a higher rate of mucositis , anorexia , neutropenia , and thrombocytopenia was seen on the CRT arm ( Arm 2 ) .", "label": "", "metadata": {}, "score": "38.05922"}
{"text": "A Singaporean trial used the INT 0099 regimen , and again demonstrated a survival benefit .Concurrent chemo - RT is now considered a standard of care in Stage III - IV NPC ; given previously different staging , some IIB patients were included in the trials and may benefit from concurrent chemotherapy as well .", "label": "", "metadata": {}, "score": "38.181015"}
{"text": "Treatment groups .A total of four treatment groups were analyzed : 1 ) S - CRT , 2 ) S - RT , 3 ) CRT , and 4 ) RT .", "label": "", "metadata": {}, "score": "38.359642"}
{"text": "Patients in the RT alone group ( RT ) received 45 Gy to their whole pelvic as well as para - aortic region up to the bottom of L1 .", "label": "", "metadata": {}, "score": "38.694473"}
{"text": "Patients in the RT alone group ( RT ) received 45 Gy to their whole pelvic as well as para - aortic region up to the bottom of L1 .", "label": "", "metadata": {}, "score": "38.694473"}
{"text": "However , the longer follow up of this study lends more proof that chemoradiation should be the standard of care in locally advanced cervical cancer , with the possibility of 5-FU and cisplatin being the optimal regimen .", "label": "", "metadata": {}, "score": "38.9702"}
{"text": "However , the longer follow up of this study lends more proof that chemoradiation should be the standard of care in locally advanced cervical cancer , with the possibility of 5-FU and cisplatin being the optimal regimen .", "label": "", "metadata": {}, "score": "38.9702"}
{"text": "Concurrent RT 66 - 73.8 Gy with cisplatin 100 mg / m2 q3 weeks .60 % completed planned treatment .Overall ; 1987 PMID 3802013 -- \" Concurrent radiotherapy and chemotherapy with cisplatin in inoperable squamous cell carcinoma of the head and neck .", "label": "", "metadata": {}, "score": "39.0285"}
{"text": "Patients in the RT alone group ( RT ) were treated with whole pelvis radiation with extension of a \" chimney \" field to the bottom of L1 to treat the PA nodes .", "label": "", "metadata": {}, "score": "39.271492"}
{"text": "The RTOG and EROTC trials relied on Kaplan - Meier analyses between treated groups but failed to account for possible confounding variables [ 24 ] .", "label": "", "metadata": {}, "score": "39.295525"}
{"text": "All patients were treated with curative intent .When the two treatment groups of S - CRT and S - RT were compared there were no statistically significant differences between any of the demographic data categories .", "label": "", "metadata": {}, "score": "39.66299"}
{"text": "71 % patients received all 3 cycles of concurrent chemo .3-years ; 2005 PMID 16170180 -- \" Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer / International Union against cancer stage III and IV nasopharyngeal cancer of the endemic variety . \"", "label": "", "metadata": {}, "score": "39.757805"}
{"text": "3-years ; 1998 PMID 9840526 -- \" Preliminary report of the Asian - Oceanian Clinical Oncology Association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal carcinoma .", "label": "", "metadata": {}, "score": "39.856087"}
{"text": "This was the first trial to do so ; however , the RT only arm had an unexpectedly low survival , compared with results from RT alone in Asian ( endemic ) studies .", "label": "", "metadata": {}, "score": "40.30174"}
{"text": "Materials and Methods .403 patients with SqCCa ( 90 % ) , AdenoCa or AdenoSqCa of the cervix , stages IIB through IVA ( IB & IIA allowed if at least 5 cm or involving pelvic LNs ) , were entered .", "label": "", "metadata": {}, "score": "40.788574"}
{"text": "Materials and Methods .403 patients with SqCCa ( 90 % ) , AdenoCa or AdenoSqCa of the cervix , stages IIB through IVA ( IB & IIA allowed if at least 5 cm or involving pelvic LNs ) , were entered .", "label": "", "metadata": {}, "score": "40.788574"}
{"text": "Group 3 patients were treated by CRT and group 4 patients received primary RT .Patients receiving CRT therapy for metastases or palliation were not included .", "label": "", "metadata": {}, "score": "41.357178"}
{"text": "Further research is necessary to determine the best chemotherapy agents , schedule , and route of delivery .This study is the only of five recent randomized trials in this area to show a decrease in local failure as well as distant failure , suggesting that the combination of cisplatin and 5FU is better than cisplatin alone .", "label": "", "metadata": {}, "score": "41.406456"}
{"text": "Further research is necessary to determine the best chemotherapy agents , schedule , and route of delivery .This study is the only of five recent randomized trials in this area to show a decrease in local failure as well as distant failure , suggesting that the combination of cisplatin and 5FU is better than cisplatin alone .", "label": "", "metadata": {}, "score": "41.406456"}
{"text": "5-years ; 2002 PMID 12001120 -- \" A prospective , randomized trial comparing neoadjuvant chemotherapy with radiotherapy alone in patients with advanced nasopharyngeal carcinoma . \"", "label": "", "metadata": {}, "score": "41.53312"}
{"text": "Illustrating this fact , only 64 % of patients in the Intergroup-0116 trial and 42 % in the Medical Research Council Adjuvant Gastric Infusional Chemotherapy ( MAGIC ) trial were able to complete their prescribed treatment courses [ 1 , 2 ] .", "label": "", "metadata": {}, "score": "41.623745"}
{"text": "PubMed View Article .Bernier J , Cooper JS , Pajak TF : Defining risk levels in locally advanced head and neck cancers : a comptive analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC ( # 22931 ) and RTOG ( # 9501 ) .", "label": "", "metadata": {}, "score": "41.687355"}
{"text": "Conclusion : Chemotherapy has small but significant benefit for OS and EFS , seen when administered concomitantly .Meta - analysis ; 2002 - PMID 12040275 - \" Combined chemoradiation versus radiation therapy alone in locally advanced nasopharyngeal carcinoma : results of a meta - analysis of 1,528 patients from six randomized trials . \"", "label": "", "metadata": {}, "score": "41.741486"}
{"text": "It should be noted , however , that only patients with T4 tumors have an improvement in local control .Currently , combined CRT should be considered the standard of care for all patients who have stage III / IV NPC regardless of WHO grade .", "label": "", "metadata": {}, "score": "41.870644"}
{"text": "It should be noted , however , that only patients with T4 tumors have an improvement in local control .Currently , combined CRT should be considered the standard of care for all patients who have stage III / IV NPC regardless of WHO grade .", "label": "", "metadata": {}, "score": "41.87065"}
{"text": "Overall tumor downstaging was seen in 18 of 28 patients ( 64 % ) who had EUS prior to starting preoperative therapy .T stage downstaging was seen in 19 patients ( 68 % ) .", "label": "", "metadata": {}, "score": "42.110104"}
{"text": "This study shows that adding adjuvant chemotherapy to S - RT improves survival outcomes in advanced OCSCC , especially in patients with ECS .Electronic supplementary material .", "label": "", "metadata": {}, "score": "42.18991"}
{"text": "This population - based cohort study demonstrates that the addition of adjuvant chemotherapy to S - RT improves survival outcomes in advanced OCSCC .Patients with ECS show the greatest survival advantage .", "label": "", "metadata": {}, "score": "42.259007"}
{"text": "Author 's Conclusions .CRT improves local control for T4 tumors in patients with endemic NPC .CRT improves DFS , DM , and OS compared to RT alone in these patients .", "label": "", "metadata": {}, "score": "42.399952"}
{"text": "Author 's Conclusions .CRT improves local control for T4 tumors in patients with endemic NPC .CRT improves DFS , DM , and OS compared to RT alone in these patients .", "label": "", "metadata": {}, "score": "42.399952"}
{"text": "During surgery , a median of 6 lymph nodes were sampled which may be insufficient for adequate dissection of regional lymph nodes .Additionally , the impact of preoperative CRT on lymph node harvest in gastric cancer is not well defined .", "label": "", "metadata": {}, "score": "42.49685"}
{"text": "PubMed View Article .Mariette C , Seitz JF , Maillard E , et al .: Surgery alone versus chemoradiotherapy followed by surgery for localized esophageal cancer : Analysis of a randomized controlled phase III trial FFCD 9901 .", "label": "", "metadata": {}, "score": "42.502075"}
{"text": "While improved disease - free survival , local or regional recurrence , and rates of distant metastases were shown in the RTOG trial , overall survival was not found to be superior .", "label": "", "metadata": {}, "score": "42.536896"}
{"text": "A substantially higher proportion of patients in the RTOG trial had N 2 - 3 disease .Both studies also did not account for confounding variables when calculating survival curves .", "label": "", "metadata": {}, "score": "42.602554"}
{"text": "The treatment options expanded in 2004 when level I evidence was established with the findings of the Radiation Therapy Oncology Group ( RTOG ) 9501 and European Organization for Research and Treatment of Cancer ( EORTC ) 22931 trials [ 3 , 4 ] .", "label": "", "metadata": {}, "score": "42.612274"}
{"text": "PubMed View Article .Becker K , Langer R , Reim D , et al .: Significance of histopathological tumor regression after neoadjuvant chemotherapy in gastric adenocarcinomas : a summary of 480 cases .", "label": "", "metadata": {}, "score": "42.62154"}
{"text": "This suggestion mirrors previous evidence that adjuvant CRT may prevent distant spread of disease [ 3 , 4 , 20 , 21 ] .While ideally an RCT specific for advanced stage OCSCC should be performed , this study serves as the first population based study confirming the survival advantage of triple modality therapy treatment for advanced stage squamous cell carcinoma of the oral cavity .", "label": "", "metadata": {}, "score": "42.658207"}
{"text": "This single - institutional series evaluates the role of preoperative chemoradiotherapy in patients with locally advanced gastric cancer .Disease - related outcomes for resected patients appear comparable to similarly staged , adjuvantly treated patients in randomized trials with acceptable rates of perioperative morbidity and mortality .", "label": "", "metadata": {}, "score": "42.811924"}
{"text": "82 patients with NPC .Arm 1 ) RT 70/35 alone vs. Arm 2 ) RT + recombinant adenovirus - p53 ( rAd - p53 ) injected intratumorally QW x8 .", "label": "", "metadata": {}, "score": "42.86382"}
{"text": "Two such examples include PET / CT , which may improve accuracy for preoperative staging [ 34 ] , and staging laparoscopy , which may identify the approximately 20 - 40 % of patients with localized disease based on preoperative CT but who demonstrate peritoneal metastases at laparoscopy [ 35 , 36 ] .", "label": "", "metadata": {}, "score": "42.89771"}
{"text": "Despite evaluating a cohort with primarily advanced disease and adverse histologic features , LC , DFS and OS rates in resected patients are comparable to similarly staged , adjuvantly treated patients in randomized trials .", "label": "", "metadata": {}, "score": "43.02957"}
{"text": "6 patients with only surgical resection were excluded owing to down - staging based on their pathology report .3 had misclassified tumours , and 5 had incomplete data .", "label": "", "metadata": {}, "score": "43.080166"}
{"text": "Patients in the chemoradiation group ( CRT ) received 45 Gy to their whole pelvis with concurrent cisplatin ( 75 mg / m2 ) and 5-FU ( 4g / m2 over 96 hour ) .", "label": "", "metadata": {}, "score": "43.164444"}
{"text": "Patients in the chemoradiation group ( CRT ) received 45 Gy to their whole pelvis with concurrent cisplatin ( 75 mg / m2 ) and 5-FU ( 4g / m2 over 96 hour ) .", "label": "", "metadata": {}, "score": "43.164444"}
{"text": "Author 's Conclusions .Pelvic radiation therapy with concurrent cisplatin and 5FU chemotherapy reduces the risk of both local and distant relapses , decreasing the overall rate of recurrence by 50 % .", "label": "", "metadata": {}, "score": "43.213028"}
{"text": "Author 's Conclusions .Pelvic radiation therapy with concurrent cisplatin and 5FU chemotherapy reduces the risk of both local and distant relapses , decreasing the overall rate of recurrence by 50 % .", "label": "", "metadata": {}, "score": "43.213028"}
{"text": "These studies are in contrast to results from the Intergroup-0116 trial where only 64 % of 281 patients were able to complete the prescribed postoperative protocol [ 1 ] .", "label": "", "metadata": {}, "score": "43.59129"}
{"text": "Chemo completed by 55 % .1998 PMID 9552031 - \" Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer : phase III randomized Intergroup study 0099 .", "label": "", "metadata": {}, "score": "43.663006"}
{"text": "This initially showed an increase in local control ( LC ) , disease specific survival ( DSS ) , and overall survival ( OS ) for the chemoradiation arm .", "label": "", "metadata": {}, "score": "43.714355"}
{"text": "Five patients ( 10 % ) had linitis plastica .Patient and tumor characteristics are reported in Table 1 .Table 1 .Median RT dose was 45 Gy ( range 21.6 - 50.4 ) .", "label": "", "metadata": {}, "score": "44.157333"}
{"text": "One randomized trial demonstrated an improvement in OS for gastric cancer patients achieving R0 resection [ 30 ] .Additionally , the MAGIC trial showed a statistically significant improvement in R0 resections among surgical patients who received preoperative ChT [ 2 ] .", "label": "", "metadata": {}, "score": "44.395233"}
{"text": "10.1093/jnci/91.24.2081 .PubMed View Article .Adelsetin DJ , Lavertu P , Saxton JP : Mature results of a phase III randomized trial comparing concurrent chemoradiotherapy with radiation therapy alone in patients with stage III and IV squamous cell carcinoma of the head and neck .", "label": "", "metadata": {}, "score": "44.60692"}
{"text": "5-year overall survival rates ( 58 % ) for the S - CRT and the S - RT group ( 40 % ) were compble to those of the EORTC study .", "label": "", "metadata": {}, "score": "44.642273"}
{"text": "Thirty - six patients ( 75 % ) underwent baseline EUS prior to CRT .Fourteen patients underwent pre - treatment laparoscopy or laparotomy .Thirty - five patients ( 73 % ) had proximal tumors , which include GE junction , cardia , and fundus tumors .", "label": "", "metadata": {}, "score": "44.7632"}
{"text": "Comparison of present series to prospective preoperative chemoradiotherapy trials in gastric cancer .In conclusion , preoperative CRT for gastric cancer is reasonably well tolerated with acceptable rates of perioperative morbidity and mortality .", "label": "", "metadata": {}, "score": "45.145508"}
{"text": "PubMed .Tepper J , Krasna MJ , Niedzwiecki D , et al .: Phase III trial of trimodality therapy with cisplatin , fluorouracil , radiotherapy , and surgery compared with surgery alone for esophageal cancer : CALGB 9781 .", "label": "", "metadata": {}, "score": "45.248505"}
{"text": "Blogs .Phase III randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with AJCC / UICC ( 1997 ) stage 3 and 4 nasopharyngeal cancer of the endemic variety .", "label": "", "metadata": {}, "score": "45.305416"}
{"text": "Despite these limitations , it is important to emphasize that many of these patients were referred for initial CRT due to concern for unresectability .This may result in a negative selection bias for patients who are referred for RT in this series , potentially leading to worse treatment - related outcomes .", "label": "", "metadata": {}, "score": "45.407684"}
{"text": "Al - Sarraf M , Pajak TF , Marcial V : Concurrent radiotherapy and chemotherapy with cisplatin in inoperable squamous cell carcinoma of the head and neck : an RTOG study .", "label": "", "metadata": {}, "score": "45.702972"}
{"text": "PubMed View Article .Schuhmacher C , Gretschel S , Lordick F , et al .: Neoadjuvant chemotherapy compared with surgery alone for locally advanced cancer of the stomach and cardia : european organisation for research and treatment of cancer randomized trial 40954 .", "label": "", "metadata": {}, "score": "45.805084"}
{"text": "These results compare favorably with the results of the EORTC and RTOG trials where ECS was the only adverse feature that showed improvement in overall survival with S - CRT in both studies [ 26 ] .", "label": "", "metadata": {}, "score": "45.95406"}
{"text": "However , a re - analysis of the data suggests that concurrent chemo - RT is only beneficial for \" low - risk \" advanced stage patients . \"", "label": "", "metadata": {}, "score": "45.97493"}
{"text": "PubMed View Article .Urba SG , Orringer MB , Turrisi A , et al .: Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma .", "label": "", "metadata": {}, "score": "45.987602"}
{"text": "221 patients , WHO II - III , T3 - 4 or N2 - 3 ( AJCC-5 ) .Arm 1 ) RT alone vs. Arm 2 ) RT + concurrent cisplatin 100 mg / m2 q3 weeks + adjuvant cisplatin 80 mg / m2 + 5-FU 1000 mg / m2 x3 cycles .", "label": "", "metadata": {}, "score": "46.06437"}
{"text": "RT 68 - 72 Gy primary tumor , involved neck 60 - 62 Gy , uninvolved neck 60 Gy .If residual tumor after RT , could boost 10 - 14 Gy EBRT or 20 - 24 Gy HDR in 4 - 5 fractions .", "label": "", "metadata": {}, "score": "46.1605"}
{"text": "2002 Dec;6(6):337 - 48 . )Treatment planning .5 patients with T4N0 NPC , treated with concurrent chemo - RT using combined photon / proton beams .", "label": "", "metadata": {}, "score": "46.17873"}
{"text": "Lastly , preoperative CRT may result in tumor downstaging , facilitating curative ( R0 ) resection rates while decreasing the risk of local tumor recurrence .", "label": "", "metadata": {}, "score": "46.18016"}
{"text": "Group 2 patients received surgical resection similar to those patients in group 1 followed by adjuvant RT within 6 - 8 weeks post - operatively .", "label": "", "metadata": {}, "score": "46.21304"}
{"text": "Similarly , a SWOG study ( Kelley et al ., JCO , 2008 ) randomized stage III NSCLC patients to gefitinib vs. placebo after treatment with definitive chemoradiation followed by consolidation therapy with docetaxel x 3 cycles .", "label": "", "metadata": {}, "score": "46.36982"}
{"text": "All patients received concurrent chemotherapy .Thirty - six patients ( 75 % ) underwent surgery .Pathologic complete response and R0 resection rates were 19 % and 86 % , respectively .", "label": "", "metadata": {}, "score": "46.377335"}
{"text": "Three phase II trials from Ajani et al . showed pCR rates ranging from 20 % to 30 % with the use of induction CT followed by concurrent CRT , [ 12 - 14 ] with associated improvements in OS and DFS in these patients .", "label": "", "metadata": {}, "score": "46.416023"}
{"text": "Trials of neoadjuvant RT or CRT compared to surgery alone have shown an overall survival ( OS ) advantage with preoperative treatment in patients with esophageal and gastric cardia adenocarcinomas [ 5 , 11 ] .", "label": "", "metadata": {}, "score": "46.528305"}
{"text": "Our data underscore the importance of achieving a R0 resection , with 3-year OS of 54 % compared to 0 % for those undergoing R1 resection .", "label": "", "metadata": {}, "score": "46.584774"}
{"text": "80 patients .Stage I - IV M0 .Arm 1 ) RT alone vs. Arm 2 ) Neoadjuvant cisplatin 80 mg / m2 , 5-FU 800 mg / m2 q3 weeks x2 cycles .", "label": "", "metadata": {}, "score": "46.677387"}
{"text": "To assess survival outcomes of advanced OCSCC treated by differing modalities .The primary goal was to determine if the addition of postoperative chemotherapy ( S - CRT ) improves survival compared to other treatment regimens .", "label": "", "metadata": {}, "score": "46.721153"}
{"text": "PubMed View Article .Lee J , Lim Do H , Kim S , et al .: Phase III trial comparing capecitabine plus cisplatin versus capecitabine plus cisplatin with concurrent capecitabine radiotherapy in completely resected gastric cancer with D2 lymph node dissection : the ARTIST trial .", "label": "", "metadata": {}, "score": "46.74099"}
{"text": "Several Phase II trials have reported encouraging results in patients with significant N disease .Meta - analysis ; 2006 PMID 16377415 -- \" Chemotherapy in locally advanced nasopharyngeal carcinoma : an individual patient data meta - analysis of eight randomized trials and 1753 patients . \"", "label": "", "metadata": {}, "score": "46.769146"}
{"text": "This study used some prospectively collected cancer registry data combined with a retrospective review of charts to determine survival rates .Not all variables were controlled in this study owing to its population - based design .", "label": "", "metadata": {}, "score": "46.808044"}
{"text": "Those with adverse features on pathology were also offered chemotherapy .Such features were defined to be ECS , LVI , and PNI .Prior to 2005 , adjuvant RT was offered for all patients with any or all adverse features , while after 2005 , patients with one or more of these features were recommended for adjuvant CRT .", "label": "", "metadata": {}, "score": "46.838135"}
{"text": "Retrospective .A wide variety of treatments described .RTOG 0225( 2003 - 2005 )Protocol PMID 19564532 -- \" Intensity - Modulated Radiation Therapy With or Without Chemotherapy for Nasopharyngeal Carcinoma : Radiation Therapy Oncology Group Phase II Trial 0225 . \"", "label": "", "metadata": {}, "score": "46.99366"}
{"text": "Conclusion : rAd - p53 was safe and biologically active , and improves tumor control and survival rate .784 patients .Induction cisplatin , bleomycin , 5-FU or cisplatin , epirubicin .", "label": "", "metadata": {}, "score": "47.01995"}
{"text": "Laramore GE , Scott CB , Al - Sarraf M : Adjuvant chemotherapy for resectable squamous cell carcinoma of the head and neck : report on intergroup study-0034 .", "label": "", "metadata": {}, "score": "47.077965"}
{"text": "The current study sought to confirm the findings of the RTOG and EORTC studies , while being site specific for OCSCC .Overall survival for stage III and IV OCSCC was found to be the highest in the S - CRT group ( Figure 1 ) .", "label": "", "metadata": {}, "score": "47.1355"}
{"text": "Table 2 demonstrates the measure of loco - regional recurrence by treatment groups .The S - CRT group showed a 21 % lower recurrence rate compared to S - RT .", "label": "", "metadata": {}, "score": "47.176865"}
{"text": "PubMed View Article .Dziegielewski PT , O'Connell DA , Klein M : Primary total laryngectomy versus organ preservation for T3/T4a laryngeal cancer : a population - based analysis of survival .", "label": "", "metadata": {}, "score": "47.527794"}
{"text": "Stahl M , Walz MK , Stuschke M , et al .: Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction .", "label": "", "metadata": {}, "score": "47.65979"}
{"text": "This translated into a significant survival gain for the CRT group .There were gains in Stage III - IVa disease , though the greatest advantage was seen in patients with Stage I - II disease .", "label": "", "metadata": {}, "score": "47.66306"}
{"text": "This translated into a significant survival gain for the CRT group .There were gains in Stage III - IVa disease , though the greatest advantage was seen in patients with Stage I - II disease .", "label": "", "metadata": {}, "score": "47.66306"}
{"text": "Only Siewert type II / III GE junction and gastric adenocarcinomas were included in this analysis [ 18 ] .Patients with direct tumor extension into adjacent organs who were still thought to be candidates for resection were included .", "label": "", "metadata": {}, "score": "47.844025"}
{"text": "Only 16 patients were unable to receive chemotherapy during their 2nd cycle .Efficacy .2- year and 4- year OS rates were also similar between the 2 arms .", "label": "", "metadata": {}, "score": "47.855488"}
{"text": "While disease - free survival was not septed by ECS status in the EORTC and RTOG trials , it was shown to significantly improve with postoperative CRT , which is congruent with our findings [ 3 , 4 ] .", "label": "", "metadata": {}, "score": "47.88926"}
{"text": "Conclusion : Concurrent chemo - RT well tolerated , but no benefit .5-years ; 2005 PMID 15812080 -- \" Overall survival after concurrent cisplatin - radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma . \"", "label": "", "metadata": {}, "score": "48.004326"}
{"text": "Blogs .Because Stage III - IV NPC has a fairly poor prognosis with RT alone , multiple efforts were made to add chemotherapy to the regimen .", "label": "", "metadata": {}, "score": "48.16057"}
{"text": "Conclusion : Concurrent chemo - RT superior to RT alone for advanced NPC .Re - analysis ; 2004 PMID 15337551 -- \" Another way to estimate outcome of advanced nasopharyngeal carcinoma -- is concurrent chemoradiotherapy adequate ? \"", "label": "", "metadata": {}, "score": "48.30593"}
{"text": "Older patients and those with higher CCI scores tended to receive RT treatments , and those with more advanced disease tended to have received S - CRT or S - RT .", "label": "", "metadata": {}, "score": "48.31099"}
{"text": "Allum WH , Hallissey MT , Ward LC , et al .: A controlled , prospective , randomised trial of adjuvant chemotherapy or radiotherapy in resectable gastric cancer : interim report .", "label": "", "metadata": {}, "score": "48.449127"}
{"text": "Pelvic Radiation with Concurrent Chemotherapy Compared with Pelvic and Para - Aortic Radiation for High - Risk Cervical Cancer .Share article .Authors : Morris M , Eifel P , Jiandong L , et al .", "label": "", "metadata": {}, "score": "48.546005"}
{"text": "A pCR was seen in 7 of 36 patients ( 19 % ) .Nine ( 25 % ) received adjuvant ChT after a R0 resection .", "label": "", "metadata": {}, "score": "48.65605"}
{"text": "10.1056/NEJMoa032641 .PubMed View Article .Morris M , Eifel PJ , Lu J : Pelvic radiation with concurrent chemotherapy compared with pelvic and p - aortic radiation for high - risk cervical cancer .", "label": "", "metadata": {}, "score": "48.688942"}
{"text": "Randomized .154 patients .Stage IV M0 ( AJCC 1992 ) .Arm 1 ) RT 70 - 72 Gy vs. Arm 2 ) weekly cisplatin 20 mg / m2 , 5-FU 2200 mg / m2 , leucovorin 120 mg / m2 x9 weeks .", "label": "", "metadata": {}, "score": "48.730316"}
{"text": "Patients in the chemoradiation group ( CRT ) received 45 Gy via external beam radiation therapy to a whole pelvis field ( without extension to include the PA nodes ) .", "label": "", "metadata": {}, "score": "48.74422"}
{"text": "Patients in the chemoradiation group ( CRT ) received 45 Gy via external beam radiation therapy to a whole pelvis field ( without extension to include the PA nodes ) .", "label": "", "metadata": {}, "score": "48.74422"}
{"text": "View Article .Cooper JS , Pajak TF , Forastiere A : Precisely defining high - risk operable head and neck tumours based on RTOG # 85 - 03 and # 88 - 24 : targets for postoperative radiochemotherapy ?", "label": "", "metadata": {}, "score": "48.869385"}
{"text": "Conclusion : Adequate tumor coverage important for LRC and survival .Lawrence Berkely Laboratory ; 1992 PMID 1618678 -- \" Recurrent locally advanced nasopharyngeal carcinoma treated with heavy charged particle irradiation . \"", "label": "", "metadata": {}, "score": "48.931503"}
{"text": "3-years ; 2005 PMID 16192584 -- \" Preliminary results of a randomized study on therapeutic gain by concurrent chemotherapy for regionally - advanced nasopharyngeal carcinoma : NPC-9901 Trial by the Hong Kong Nasopharyngeal Cancer Study Group . \"", "label": "", "metadata": {}, "score": "48.99754"}
{"text": "One patient who underwent gastrectomy was found to have peritoneal carcinomatosis on final pathology despite negative intraoperative frozen sections .For the entire cohort , the first site of failure was local - regional only in 3 patients , synchronous local - regional and distant in 5 patients and distant only in 19 patients .", "label": "", "metadata": {}, "score": "49.007187"}
{"text": "[ 24 , 25 ] Further advancement in OCSCC treatment did n't come until 2004 with the RTOG 9501 and EORTC 22931 trials which suggested that improved disease - free survival in addition to local and regional control can be achieved with the addition of adjuvant chemotherapy to postoperative RT .", "label": "", "metadata": {}, "score": "49.07218"}
{"text": "Randomized .Trial stopped early due to significant survival benefit .147 patients .NPC Stage III - IV ( Stage IV 91 % ; but also included few N1 patients , which are IIB today ) , histology WHO I ( 25 % ) , WHO II ( 35 % ) , WHO III ( 41 % ) .", "label": "", "metadata": {}, "score": "49.282616"}
{"text": "Four patients received one cycle of induction fluoropyrimidine - based ChT prior to starting RT .Six patients ( 13 % ) required a treatment break for a median of 4 days ( range 2 - 23 ) .", "label": "", "metadata": {}, "score": "49.487526"}
{"text": "Randomized .Arm 1 ) RT with concurrent cisplatin 40 mg / m2 q week vs. Arm 2 ) RT alone .RT 66 Gy , parapharyngeal boost 10 - 20 Gy allowed .", "label": "", "metadata": {}, "score": "49.514446"}
{"text": "No difference with concurrent chemo .Conclusion : Concurrent chemo - RT superior for low - risk patients , but inadequate for high - risk patients .", "label": "", "metadata": {}, "score": "49.65924"}
{"text": "Multi - field external beam RT plans were typically designed to cover the primary tumor and local - regional lymph node basins .In recent years , a deep inspiratory breath - hold technique during RT was utilized for patients with significant tumor motion .", "label": "", "metadata": {}, "score": "49.690506"}
{"text": "Conclusion : Neoadjuvant chemo did n't improve DFS or OS .Asian - Oceanic Clinical Oncology Association ( AOCOA ) ( 1989 - 1993 ) -- cisplatin , epirubicin .", "label": "", "metadata": {}, "score": "49.79757"}
{"text": "The actuarial local recurrence rate in our cohort was 28 % for all patients and 27 % in the subset of patients who underwent gastrectomy .", "label": "", "metadata": {}, "score": "49.817192"}
{"text": "Single institution experiences examining a neoadjuvant approach for gastric cancer have also been published [ 15 - 17 ] , but data looking at preoperative CRT without induction ChT are limited .", "label": "", "metadata": {}, "score": "50.081352"}
{"text": "Dose 70 - 74 Gy primary tumor and LN+ , 50 - 60 Gy N0 neck .Chemo completed by 94 % patients .5-years ; 2003 PMID 12586799 -- \" Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma : positive effect on overall and progression - free survival . \"", "label": "", "metadata": {}, "score": "50.175014"}
{"text": "The HOG study ( Hanna et al ., JCO , 2008 ) randomized patients with locally advanced NSCLC to 3 cycles of consolidation docetaxel vs. observation after definitive treatment with concurrent chemoradiation .", "label": "", "metadata": {}, "score": "50.51012"}
{"text": "The objective of this study was to assess survival outcomes of advanced OCSCC treated by differing modalities .The primary goal was to determine if S - CRT improves survival over all other treatment regimens .", "label": "", "metadata": {}, "score": "50.53535"}
{"text": "Bang YJ , Kim YW , Yang HK , et al .: Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy ( CLASSIC ) : a phase 3 open - label , randomised controlled trial .", "label": "", "metadata": {}, "score": "50.573467"}
{"text": "Preoperative CRT was well tolerated in our series , with 96 % of patients able to complete the prescribed treatment course and only six patients requiring treatment break .", "label": "", "metadata": {}, "score": "50.831467"}
{"text": "Clinical / Scientific Implications .With several studies documenting increased efficacy of chemoradiation over radiation alone in the treatment of locally advanced cervical cancer , this has become the indisputable standard of care for these patients .", "label": "", "metadata": {}, "score": "50.865948"}
{"text": "Clinical / Scientific Implications .With several studies documenting increased efficacy of chemoradiation over radiation alone in the treatment of locally advanced cervical cancer , this has become the indisputable standard of care for these patients .", "label": "", "metadata": {}, "score": "50.865948"}
{"text": "Source : N Engl J Med 1999 ; 340:1137 - 1143 .Background .Cervical cancers that are bulky , extend to parametrial / pelvic tissues and/or involve pelvic lymph nodes benefit from external - beam plus intracavitary radiation .", "label": "", "metadata": {}, "score": "50.92749"}
{"text": "4 recurrences : 2 LR and 2 DM .All patients with recurrence did not have chemo .Toxicity : 1 treatment - related death from adjuvant chemo ; 2 late carotid pseudoaneurysms with torrential epistaxis .", "label": "", "metadata": {}, "score": "50.932358"}
{"text": "PubMed View Article .Lowy AM , Feig BW , Janjan N , et al .: A pilot study of preoperative chemoradiotherapy for resectable gastric cancer .", "label": "", "metadata": {}, "score": "51.371185"}
{"text": "Results .From July 2005 to May 2009 , 288 patients were enrolled and 279 pts received CT / RT .201 patients ( 72 % ) had at least stable disease and were randomized .", "label": "", "metadata": {}, "score": "51.408905"}
{"text": "4-years ; 1988 PMID 3047335 - \" Adjuvant chemotherapy with vincristine , cyclophosphamide , and doxorubicin after radiotherapy in local - regional nasopharyngeal cancer : results of a 4-year multicenter randomized study . \"", "label": "", "metadata": {}, "score": "51.685284"}
{"text": "Although grade 3 - 4 acute side effects occurred more frequently in the CRT group , there were no differences in major late complications ( RT , 14 % versus CRT , 12 % ) .", "label": "", "metadata": {}, "score": "51.749344"}
{"text": "Although grade 3 - 4 acute side effects occurred more frequently in the CRT group , there were no differences in major late complications ( RT , 14 % versus CRT , 12 % ) .", "label": "", "metadata": {}, "score": "51.749344"}
{"text": "Guidelines for preoperative RT planning for gastric cancer have been previously published and can serve as a framework for our general approach to treatment field design [ 19 ] .", "label": "", "metadata": {}, "score": "51.79033"}
{"text": "Blogs .Pelvic Radiation With Concurrent Chemotherapy versus Pelvic and Para - Aortic Radiation for High - Risk Cervical Cancer : An Update of RTOG 90 - 01 .", "label": "", "metadata": {}, "score": "51.891796"}
{"text": "Patients who were selected for primary RT treatment either declined surgical treatment or were found to be medically unfit for a prolonged operation .Outcomes .", "label": "", "metadata": {}, "score": "52.00236"}
{"text": "PubMed View Article .Bonenkamp JJ , Songun I , Hermans J , et al .: Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients .", "label": "", "metadata": {}, "score": "52.022305"}
{"text": "10.1002/hed.2890060303 .PubMed View Article .Cooper JS , Guo M , Herskovic A : Chemoradiotherapy of locally advanced esophageal cancer : long - term follow - up of a prospective randomized trial ( RTOG 85 - 01 ) .", "label": "", "metadata": {}, "score": "52.085854"}
{"text": "However , lymphangiogram has documented high sensitivity in predicting PA nodal metastases .The question remains of what is the best chemotherapy regimen to use in this situation ?", "label": "", "metadata": {}, "score": "52.398975"}
{"text": "However , lymphangiogram has documented high sensitivity in predicting PA nodal metastases .The question remains of what is the best chemotherapy regimen to use in this situation ?", "label": "", "metadata": {}, "score": "52.398975"}
{"text": "Tumor epicenter , GE junction involvement and tumor ( T ) and nodal ( N ) staging were determined using upper endoscopy , radiographic imaging and/or endoscopic ultrasound ( EUS ) .", "label": "", "metadata": {}, "score": "52.44297"}
{"text": "In this study , pCR was the only statistically significant predictor of LC based on multivariable analysis [ 15 ] .Similarly , another recent report showed lower recurrence rates and greater OS , DFS and relapse - free survival in the pCR group versus the non - pCR group [ 16 ] .", "label": "", "metadata": {}, "score": "52.644028"}
{"text": "Thirty - one ( 65 % ) were clinically node positive .Staging PET scan was used for 19 patients ( 40 % ) and CT scan was used for 28 ( 59 % ) .", "label": "", "metadata": {}, "score": "52.660152"}
{"text": "Similarly , previously published data from our institution suggested that induction therapy for esophagogastrectomy patients was not associated with an increased risk of surgical mortality on multivariable analysis [ 28 ] .", "label": "", "metadata": {}, "score": "52.702366"}
{"text": "Thus , we contend that neoadjuvant CRT can be a feasible and effective selection tool to identify patients with locally advanced disease who could proceed to surgery .", "label": "", "metadata": {}, "score": "52.738373"}
{"text": "CO;2-F. PubMed View Article .Bernier J , Cooper JS : Chemoradiation after surgery for high - risk head and neck cancer patients : how strong is the evidence ?", "label": "", "metadata": {}, "score": "52.837223"}
{"text": "The treatment options expanded in 2004 when two international trials showed the addition of postoperative chemotherapy to radiation improved outcomes .These trials were , however not oral cavity site specific .", "label": "", "metadata": {}, "score": "52.861526"}
{"text": "In the POET trial by Stahl et al . , preoperative CRT was associated with a non - significant increase in postoperative mortality compared to a ChT alone approach [ 27 ] .", "label": "", "metadata": {}, "score": "53.09274"}
{"text": "Acute and late toxicity data assessing neoadjuvant CRT for gastric cancer are limited [ 12 , 13 , 24 ] .With respect to late toxicity , 5 % of patients in RTOG 9904 evaluating preoperative CRT experienced late grade 3 toxicity [ 12 ] , which is lower than in our series .", "label": "", "metadata": {}, "score": "53.25193"}
{"text": "Figure 2 demonstrates survival results of S - CRT versus S - RT grouped by adverse feature found on pathology .( A ) Overall survival , ( B ) disease - specific survival , ( C ) disease - free survival , and ( D ) metastasis - free survival rates for patients with stage III or IV oral cavity tumours according to treatment group ( Cox regression analysis ) .", "label": "", "metadata": {}, "score": "53.408413"}
{"text": "At 42 months median follow - up , 3-year actuarial OS was 40 % .For patients undergoing surgery , 3-year OS , LC and DFS were 50 % , 73 % and 41 % , respectively .", "label": "", "metadata": {}, "score": "53.45936"}
{"text": "Definitive chemoradiation : .Chemotherapy : NVBo 50 mg / m\u00b2 D1 , D8 , D15 + P 20 mg / m\u00b2 D1-D4 q4w for 2 cycles .", "label": "", "metadata": {}, "score": "53.47784"}
{"text": "10.1002/cncr.25364 .PubMed View Article .Dwivedi RC , Roe JW , Kazi RA : Outcome assessment in oral and oropharyngeal cancers .J Otolaryngol Head Neck Surg .", "label": "", "metadata": {}, "score": "53.502724"}
{"text": "10.1056/NEJM199904153401501 .PubMed View Article .Johnson JT , Barnes EL , Myers EN : The extracapsular spread of tumors in cervical node metastasis .", "label": "", "metadata": {}, "score": "53.52352"}
{"text": "Materials and Methods .This is a phase III randomized control trial .Inclusion criteria : untreated histologically or cytologically confirmed NSCLC , inoperable stage IIIA ( N2 ) or stage IIIB amenable to definitive chemoradiotherapy .", "label": "", "metadata": {}, "score": "53.52592"}
{"text": "However , the authors note that there is no survival advantage for consolidation chemotherapy in this unselected group .Clinical Implications .The data presented here , demonstrating no significant benefit in survival with consolidation chemotherapy , are consistent with multiple prior studies evaluating the role of consolidation chemotherapy after definitive therapy with concurrent chemoradiation in locally advanced NSCLC .", "label": "", "metadata": {}, "score": "53.536564"}
{"text": "Clinical / Scientific Implications .The results of this study are similar to those found in the large Intergroup trial of NPC that has previously been mentioned .", "label": "", "metadata": {}, "score": "53.674137"}
{"text": "Clinical / Scientific Implications .The results of this study are similar to those found in the large Intergroup trial of NPC that has previously been mentioned .", "label": "", "metadata": {}, "score": "53.674137"}
{"text": "The median age was 60.3 years .About 50 % were squamous cell carcinoma and 36 % were adenocarcinoma .A larger number of patients had stage IIIB disease ( 82 % ) .", "label": "", "metadata": {}, "score": "53.68271"}
{"text": "The authors conclude that definitive chemoradiation with vinorelbine and cisplatin has a high level of efficacy ( OR 60.7 % ; DCR 86.0 % ) and low toxicity profile .", "label": "", "metadata": {}, "score": "53.760975"}
{"text": "10 died of other cancers and 17 died of non - cancer related causes .Figure 1 demonstrates Cox - regression analysis for estimated overall , disease - specific , disease - free , and metastasis - free survival by treatment group for all patients of this study .", "label": "", "metadata": {}, "score": "53.78688"}
{"text": "CO;2-Y. View Article .Brizel DM , Albers ME , Fisher SR : Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer .", "label": "", "metadata": {}, "score": "53.977905"}
{"text": "J Clin Oncol .1998 Apr;16(4):1310 - 7 .Median F / U 2.7 years .3-year outcome : PFS chemo - RT 69 % vs. RT alone 24 % ( SS ) ; OS 78 % vs 47 % ( SS ) .", "label": "", "metadata": {}, "score": "53.978294"}
{"text": "Conclusion : Adjuvant chemo after RT offers no benefit for OS or RFS .Italian NRC ( 1979 - 83 ) -- observation vs. vincristine / cyclophosphamide / adriamycin .", "label": "", "metadata": {}, "score": "54.034546"}
{"text": "If patients had at least stable disease at the end of CT - RT , they were randomized to : .Arm A : NVBo 60 - 80 mg / m\u00b2 D1D8 + P 80 mg / m\u00b2 D1 q3w for 2 cycles + best supportive case .", "label": "", "metadata": {}, "score": "54.13439"}
{"text": "Hematologic- the major toxicity was expected neutropenia .Grade 3/4 neutropenia was higher in the consolidation chemotherapy group : 11.7 % vs. 5.7 % in the best supportive care group .", "label": "", "metadata": {}, "score": "54.228127"}
{"text": "It is possible that these comparative differences may be attributable to variations in scoring toxicity between studies .Thirty - day postoperative mortality was 6 % in our analysis , which is consistent with previously reported mortality rates examining neoadjuvant CRT for gastric [ 14 , 24 ] and esophageal malignancies [ 5 , 8 , 26 ] .", "label": "", "metadata": {}, "score": "54.27047"}
{"text": "Cisplatin given every 3 weeks at 100 mg / m2 x 3 cycles .Then adjuvant chemo began 4 weeks after finishing RT : cisplatin 80 mg / m2 and 5-FU 1000 mg / m2/d by 96-hr infusion q4w x 3 cycles .", "label": "", "metadata": {}, "score": "54.281624"}
{"text": "Treatment protocols on CRT in addition to adjuvant CRT or RT were not clearly defined at either the Cross Cancer Institute or the Tom Baker Cancer Center .", "label": "", "metadata": {}, "score": "54.3149"}
{"text": "PubMed View Article .Sauer R , Becker H , Hohenberger W , et al .: Preoperative versus postoperative chemoradiotherapy for rectal cancer .N Engl J Med 2004 , 351 : 1731 - 1740 .", "label": "", "metadata": {}, "score": "54.363853"}
{"text": "As a result , the use of consolidation chemotherapy after definitive chemoradiation has been under investigation to potentially decrease the risk of distant failure and improve overall survival .", "label": "", "metadata": {}, "score": "54.402214"}
{"text": "Early studies exploring concurrent chemoradiotherapy to eradicate micrometastases and radiosensitize tumor have been criticized because of their use of deficient radiotherapy techniques as well as the lack of appropriate control groups ( radiation alone ) .", "label": "", "metadata": {}, "score": "54.610928"}
{"text": "Early studies exploring concurrent chemoradiotherapy to eradicate micrometastases and radiosensitize tumor have been criticized because of their use of deficient radiotherapy techniques as well as the lack of appropriate control groups ( radiation alone ) .", "label": "", "metadata": {}, "score": "54.610928"}
{"text": "Preoperative CRT for gastric cancer is well tolerated with acceptable rates of perioperative morbidity and mortality .In this patient cohort with primarily advanced disease , OS , LC and DFS rates in resected patients are comparable to similarly staged , adjuvantly treated patients in randomized trials .", "label": "", "metadata": {}, "score": "54.65951"}
{"text": "This study was presented by Dr. Han Zhang at the 66th Canadian Society of Otolaryngology - Head and Neck Surgery annual meeting , Poliquin Resident 's Competition in Toronto , ON on May 20 - 22 , 2012 .", "label": "", "metadata": {}, "score": "54.7282"}
{"text": "Nasopharynx CR 82 % .Conclusion : Concurrent cisplatin effective and safe in advanced H&N .NPC Subset ; 1990 PMID 2199621 -- \" Chemo - radiotherapy in patients with locally advanced nasopharyngeal carcinoma : a radiation therapy oncology group study . \"", "label": "", "metadata": {}, "score": "54.7637"}
{"text": "Patients were grouped by treatment .Results .Results were similar for disease - specific , disease - free , and metastasis free survival with S - CRT being favoured .", "label": "", "metadata": {}, "score": "54.872627"}
{"text": "Concurrent chemo - radiotherapy ( CT - RT ) is considered the standard treatment for patients with stage III NSCLC .Treatment failure in patients with NSCLC , particularly locally advanced NSCLC , is predominantly distant .", "label": "", "metadata": {}, "score": "54.96708"}
{"text": "PubMed View Article .van Hagen P , Hulshof MC , van Lanschot JJ , et al .: Preoperative chemoradiotherapy for esophageal or junctional cancer .", "label": "", "metadata": {}, "score": "55.169617"}
{"text": "Conclusion : Chemo - RT in NPC effective , should be evaluated in phase III .Beijing Hospital , China ( 2001 - 2003 ) -- RT + /- recombinant adenovirus - p53 .", "label": "", "metadata": {}, "score": "55.200874"}
{"text": "Conclusion : Induction chemo - RT modest decrease in DFS , but no impact on OS .Concurrent chemo - RT should remain standard of care .", "label": "", "metadata": {}, "score": "55.481808"}
{"text": "Kaplan - Meier estimates for overall survival , disease - free survival and local control , all patients .For the 36 patients who underwent surgery , the first site of failure was local - regional only in 2 patients , synchronous local - regional and distant in 5 patients , and distant only in 10 patients .", "label": "", "metadata": {}, "score": "55.530357"}
{"text": "Staging .Staging of the tumours was clinical and according to the seventh edition of the American Joint Committee on Cancer ( AJCC )TNM staging manual ( 2009 ) [", "label": "", "metadata": {}, "score": "55.56424"}
{"text": "Although LC was 100 % in the pCR group , the low absolute numbers of patients and high distant failure rates potentially diluted any impact of pCR within our study .", "label": "", "metadata": {}, "score": "55.776295"}
{"text": "RTOG 81 - 17 ( 1981 - 1984 ) .Phase II .124 patients , locally advanced inoperable H&N cancer ( oropharynx 39 % , nasopharynx 22 % , oral cavity 18 % , hypopharynx 7 % , larynx 7 % , sinuses 7 % ) .", "label": "", "metadata": {}, "score": "55.77928"}
{"text": "PubMed View Article .Stell PM , Rawson NS : Adjuvant chemotherapy in head and neck cancer .Br J Cancer .Jacobs C , Makuch R : Efficacy of adjuvant chemotherapy for patients with resectable head and neck cancer : a subset analysis of head and neck contracts program .", "label": "", "metadata": {}, "score": "55.87555"}
{"text": "Despite regimens that allow for organ preservation in selected patients , surgical resection followed by postoperative RT has become the standard of care for stage III and IV OCSCC [ 19 - 21 ] .", "label": "", "metadata": {}, "score": "55.911247"}
{"text": "34 patients concurrent cisplatin ( initial 11 were RT only to establish safety , subsequent patients offered INT 0099 protocol ) .Median F / U 2.1 years .", "label": "", "metadata": {}, "score": "56.056786"}
{"text": "Cooper JS , Pajak TF , Forastiere AA : Postoperative concurrent radiotherapy and chemotherapy for high - risk squamous - cell carcinoma of the head and neck .", "label": "", "metadata": {}, "score": "56.217335"}
{"text": "229 NPC patients , T1N1-T4N3 .Complete remission after RT , then Arm 1 ) observation vs. Arm 2 ) VCA ( vincristine , cyclophosphamide , adriamycin ) x 6 monthly cycles .", "label": "", "metadata": {}, "score": "56.300247"}
{"text": "No pneumonitis was seen in the consolidation arm , but 2 % of patients in the best supportive care arm developed pneumonitis .Patients treated with consolidation chemotherapy experienced slightly higher rates of grade 3 nausea ( 4.7 vs. 2.9 % ) .", "label": "", "metadata": {}, "score": "56.42026"}
{"text": "286 patients .Arm 1 ) neoadjuvant cisplatin 60 mg / m2 + epirubicin 110 mg / m2 x2 - 3 cycles followed by RT vs. Arm 2 ) RT alone .", "label": "", "metadata": {}, "score": "56.504044"}
{"text": "International Nasopharynx Cancer Study Group : VUMCA I ( 1989 - 1993 ) -- cisplatin , epirubicin , bleomycin .Randomized .339 patients .Undifferentiated carcinoma ( WHO 2 or 3 ) , any T stage , N2 - 3 , M0 .", "label": "", "metadata": {}, "score": "56.694065"}
{"text": ": Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction .N Engl J Med 2001 , 345 : 725 - 730 .", "label": "", "metadata": {}, "score": "56.76312"}
{"text": "J Clin Oncol .1988 Sep;6(9):1401 - 10 . )Outcome : 4-year RFS observation 56 % vs. chemo 58 % ( NS ) , no difference in OS ; Similar pattern of failure with distant mets in about 50 % who failed .", "label": "", "metadata": {}, "score": "56.7775"}
{"text": "Treatment of advanced stage oral cavity squamous cell carcinoma ( OCSCC ) has classically involved surgical resection with postoperative adjuvant radiotherapy ( S - RT ) [ 2 ] .", "label": "", "metadata": {}, "score": "56.78267"}
{"text": "The small numbers limit the power of the study and the selection effect may have resulted in bias .Given the pronounced tail on the survival curve at 20 % survival , it is possible that certain subgroups of patients may benefit from consolidation chemotherapy .", "label": "", "metadata": {}, "score": "56.80481"}
{"text": "Calais G , Alfonsi M , Bardet E : Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced - stage oropharynx carcinoma .", "label": "", "metadata": {}, "score": "56.898716"}
{"text": "Accelerated same regimen but 6 days / week .Technique 2D or 3D - CRT or IMRT boost .Concurrent chemo cisplatin 100 mg / m2 q3 weeks , adjuvant chemo cisplatin 80 mg / m2 + 5-FU 1000 mg / m2 . 3-years ; 2006 PMID 16904519 -- \" Preliminary results of a randomized study ( NPC-9902 Trial ) on therapeutic gain by concurrent chemotherapy and/or accelerated fractionation for locally advanced nasopharyngeal carcinoma . \"", "label": "", "metadata": {}, "score": "56.943268"}
{"text": "( Chi KH , Int J Radiat Oncol Biol Phys .2002 Apr 1;52(5):1238 - 44 . )Median F / U 4.1 years .Outcome : 5-year OS RT alone 60 % vs. adjuvant chemo 50 % ( NS ) , RFS 54 % vs. 54 % ( NS ) .", "label": "", "metadata": {}, "score": "57.012768"}
{"text": "This discrepancy could be attributed to varied sensitivity of different head and neck sites to radiotherapy that was not septed in the RTOG trial [ 3 ] .", "label": "", "metadata": {}, "score": "57.16861"}
{"text": "2005 Feb 20;23(6):1118 - 24 . )Outcome : 5-year DFS induction chemo 63 % vs. RT 58 % ( SS ) , OS 62 % vs. 58 % ( NS ) .", "label": "", "metadata": {}, "score": "57.188255"}
{"text": "2006 Feb 1;64(2):374 - 81 .Epub 2005 Oct 5 . )Retrospective .50 patients , T3-T4 NPC ( Stage III 28 % , Stage IVA / B 72 % ) .", "label": "", "metadata": {}, "score": "57.240944"}
{"text": "PubMed View Article .Lowy AM , Mansfield PF , Leach SD , et al .: Laparoscopic staging for gastric cancer .Surgery 1996 , 119 : 611 - 614 .", "label": "", "metadata": {}, "score": "57.305866"}
{"text": "First , our cohort is limited by small patient numbers , resulting in few total events and wide confidence intervals for actuarial data .Second , clinical and pathological data were not collected prospectively which allows for selection bias to be introduced .", "label": "", "metadata": {}, "score": "57.44185"}
{"text": "All patients were followed at regional cancer treatment centers at regular intervals following treatment .Dates of follow - up up to March 1 , 2012 were recorded .", "label": "", "metadata": {}, "score": "57.472206"}
{"text": "PubMed View Article .Chen J , Cheong JH , Yun MJ , et al .: Improvement in preoperative staging of gastric adenocarcinoma with positron emission tomography .", "label": "", "metadata": {}, "score": "57.50258"}
{"text": "10.1634/theoncologist.10 - 3 - 215 .PubMed View Article .Jacobs JR , Paja TF , al - Sarraf M : Chemotherapy following surgery for head and neck cancer : a radiation therapy oncology group study .", "label": "", "metadata": {}, "score": "57.553123"}
{"text": "Of these , 311 patients were found to have stage III or IV oral cavity tumors .25 had palliative treatment , 15 refused any form of treatment , and 7 had therapy outside of Alberta .", "label": "", "metadata": {}, "score": "57.579514"}
{"text": "All disease - related endpoints were calculated from the preoperative therapy start date .Testing for time to event differences between groups was performed using the log - rank ( Mantel - Cox ) test .", "label": "", "metadata": {}, "score": "57.6786"}
{"text": "Single institution experiences using either preoperative ChT and/or CRT have also been described [ 15 - 17 ] , although the data examining a neoadjuvant approach in gastric cancer remains limited .", "label": "", "metadata": {}, "score": "57.687103"}
{"text": "Methods .This Institutional Review Board - approved study included patients who underwent preoperative CRT for non - metastatic gastroesophageal ( GE ) junction and gastric adenocarcinoma at Duke University Medical Center between 1987 and 2009 .", "label": "", "metadata": {}, "score": "57.853123"}
{"text": "10.1001/jama.281.17.1623 .PubMed View Article .A - Sarraf M , LeBlanc M , Giri PG : Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer : phase III randomized Intergroup study 0099 .", "label": "", "metadata": {}, "score": "57.901703"}
{"text": "10.1056/NEJMoa032646 .PubMed View Article .Bernier K , Domenge C , Ozahin M : Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer .", "label": "", "metadata": {}, "score": "57.976135"}
{"text": "( Kwong DL , J Clin Oncol .2004 Jul 1;22(13):2643 - 53 . ) 3-year adjuvant chemo vs. none FFS 62 % vs. 65 % ( NS ) , OS 80 % vs. 83 % ( NS ) , no difference on LRC or DM .", "label": "", "metadata": {}, "score": "58.105003"}
{"text": "( Kwong DL , J Clin Oncol .2004 Jul 1;22(13):2643 - 53 . ) 3-year adjuvant chemo vs. none FFS 62 % vs. 65 % ( NS ) , OS 80 % vs. 83 % ( NS ) , no difference on LRC or DM .", "label": "", "metadata": {}, "score": "58.105003"}
{"text": "( Chan AT , J Clin Oncol .2002 Apr 15;20(8):2038 - 44 . )Median F / U 2.7 years .Outcome : 2-year PFS chemo - RT 76 % vs. RT alone 69 % ( NS ) .", "label": "", "metadata": {}, "score": "58.217678"}
{"text": "OS in patients with Stage I - II disease was 79 % vs. 55 % .Local failure was 18 % vs. 34 % .Development of DM was 18 % vs. 31 % .", "label": "", "metadata": {}, "score": "58.35679"}
{"text": "OS in patients with Stage I - II disease was 79 % vs. 55 % .Local failure was 18 % vs. 34 % .Development of DM was 18 % vs. 31 % .", "label": "", "metadata": {}, "score": "58.35679"}
{"text": "2-years ; 1995 PMID 7558945 - \" A prospective randomized study of chemotherapy adjunctive to definitive radiotherapy in advanced nasopharyngeal carcinoma . \"( Chan AT , Int J Radiat Oncol Biol Phys .", "label": "", "metadata": {}, "score": "58.436203"}
{"text": "Optimizing ChT regimens , including the use of novel conventional and targeted biologic therapies , may be a potential way to improve pathologic response and R0 resection rates , reduce distant recurrences , and improve survival rates in future trials examining preoperative CRT .", "label": "", "metadata": {}, "score": "58.43933"}
{"text": "Median F / U 5.6 years .5-years ; 2005 PMID 15657403 -- \" Long - term survival after cisplatin - based induction chemotherapy and radiotherapy for nasopharyngeal carcinoma : a pooled data analysis of two phase III trials . \"", "label": "", "metadata": {}, "score": "58.471107"}
{"text": "Importantly , patients with rapidly progressive disease or with occult metastatic disease at presentation were spared the morbidity associated with surgical resection with this treatment approach .", "label": "", "metadata": {}, "score": "58.597168"}
{"text": "( Al - Sarraf M , Cancer .1987 Jan 15;59(2):259 - 65 . )Severe toxicity : stomatitis 31 % , leukopenia 11 % , anemia 8 % , N / V 6 % .", "label": "", "metadata": {}, "score": "58.66108"}
{"text": "2012 , in press .Kang CJ , Liao CT , Hsueh C : Outcome analysis of patients with well - differentiated oral cavity squamous cell carcinoma .", "label": "", "metadata": {}, "score": "58.68464"}
{"text": "Arm 1 : RT 70Gy total dose in 35 fractions using conventional RT techniques .Arm 2 : The same RT given concurrently with cisplatin ( 25 mg / m2 d1 - 4 on wks 1,4,7 of RT ) followed by cisplatin ( 20 mg / m2 d1 - 4 ) + 5-FU ( 1000mg / m2 d1 - 4 ) on wks 11 , 15 , 19 .", "label": "", "metadata": {}, "score": "58.806778"}
{"text": "Arm 1 : RT 70Gy total dose in 35 fractions using conventional RT techniques .Arm 2 : The same RT given concurrently with cisplatin ( 25 mg / m2 d1 - 4 on wks 1,4,7 of RT ) followed by cisplatin ( 20 mg / m2 d1 - 4 ) + 5-FU ( 1000mg / m2 d1 - 4 ) on wks 11 , 15 , 19 .", "label": "", "metadata": {}, "score": "58.806778"}
{"text": "For patients stage I - II disease , OS was 79 % vs. 55 % .Local failure was 18 % vs. 34 % .Development of DM was 18 % vs. 31 % .", "label": "", "metadata": {}, "score": "58.922924"}
{"text": "For patients stage I - II disease , OS was 79 % vs. 55 % .Local failure was 18 % vs. 34 % .Development of DM was 18 % vs. 31 % .", "label": "", "metadata": {}, "score": "58.922924"}
{"text": "Smith DD , Schwarz RR , Schwarz RE : Impact of total lymph node count on staging and survival after gastrectomy for gastric cancer : data from a large US - population database .", "label": "", "metadata": {}, "score": "58.947044"}
{"text": "1990 Aug;8(8):1342 - 51 . )Subset analysis , 27 NPC patients , 96 % Stage IV , 67 % poorly differentiated .Median F / U 1.5 years .", "label": "", "metadata": {}, "score": "59.08242"}
{"text": "Table 1 demonstrates patient demographic and tumour variables .Two hundred and twenty two patients were staged according to the seventh edition of the AJCC cancer staging manual [ 17 ] .", "label": "", "metadata": {}, "score": "59.126953"}
{"text": "Bonenkamp JJ , Hermans J , Sasako M , et al .: Extended lymph - node dissection for gastric cancer .N Engl J Med 1999 , 340 : 908 - 914 .", "label": "", "metadata": {}, "score": "59.142967"}
{"text": "Abstract .Background .To examine toxicity and outcomes for patients treated with preoperative chemoradiotherapy ( CRT ) for gastric cancer .Methods .Patients with gastroesophageal ( GE ) junction ( Siewert type II and III ) or gastric adenocarcinoma who underwent neoadjuvant CRT followed by planned surgical resection at Duke University between 1987 and 2009 were reviewed .", "label": "", "metadata": {}, "score": "59.217205"}
{"text": "Further studies need to focus on identifying these subgroups of patients by analyzing biomarkers of other specific patient or tumor characteristics .Taken together , concurrent CRT without consolidation CT remains the standard of care .", "label": "", "metadata": {}, "score": "59.29959"}
{"text": "Results .Median duration of radiotherapy was 58 days , with a mean dose to point A of 89 Gy in each group .Outcomes were significantly better for patients treated with chemoradiation .", "label": "", "metadata": {}, "score": "59.47894"}
{"text": "Results .Median duration of radiotherapy was 58 days , with a mean dose to point A of 89 Gy in each group .Outcomes were significantly better for patients treated with chemoradiation .", "label": "", "metadata": {}, "score": "59.47894"}
{"text": "PubMed View Article .Matzinger O , Gerber E , Bernstein Z , et al .: EORTC - ROG expert opinion : radiotherapy volume and treatment guidelines for neoadjuvant radiation of adenocarcinomas of the gastroesophageal junction and the stomach .", "label": "", "metadata": {}, "score": "59.499336"}
{"text": "PNI positive , and ( C ) LVI positive overall and disease - free survival for patients with stage III or IV oral cavity tumours according to treatment group ( Cox regression analysis ) .", "label": "", "metadata": {}, "score": "59.538773"}
{"text": "2003 Feb 15;21(4):631 - 7 . )Median F / U 5.4 years .5-year outcome : PFS RT alone 53 % vs. chemo - RT 72 % ( SS ) ; OS 54 % vs. 72 % ( SS ) .", "label": "", "metadata": {}, "score": "59.632565"}
{"text": "2009 Jun 29 .[ Epub ahead of print ] ) .Phase II .Multi - institutional IMRT use .68 patients , Stage I - IVb NPC ( 94 % WHO type 2 - 3 ) .", "label": "", "metadata": {}, "score": "59.727554"}
{"text": "PubMed View Article .Walsh TN , Noonan N , Hollywood D , et al .: A comparison of multimodal therapy and surgery for esophageal adenocarcinoma .", "label": "", "metadata": {}, "score": "59.77927"}
{"text": "2005 Sep 20;23(27):6730 - 8 . )Median F / U 3.2 years .Outcome : 3-year DFS chemo - RT 72 % vs. RT 53 % ( SS ) ; OS 80 % vs. 65 % ( SS ) ; 2-year DM chemo - RT 13 % vs. RT alone 30 % ( SS ) .", "label": "", "metadata": {}, "score": "59.796124"}
{"text": "Int J Radiat Oncol Biol Phys 2011 , 80 : 698 - 704 .PubMed View Article .Siewert JR , Stein HJ : Classification of adenocarcinoma of the oesophagogastric junction .", "label": "", "metadata": {}, "score": "59.942642"}
{"text": "Major late complications were 14 % ( RT ) vs. 12 % ( CRT ) .They were mostly rectal or large bowel complications .Author 's Conclusions .", "label": "", "metadata": {}, "score": "59.959663"}
{"text": "Major late complications were 14 % ( RT ) vs. 12 % ( CRT ) .They were mostly rectal or large bowel complications .Author 's Conclusions .", "label": "", "metadata": {}, "score": "59.959663"}
{"text": "J Chronic Dis .PubMed View Article .Int J Radiat Oncol Biol Phys .PubMed View Article .Cachin Y , Eschwege F : Combination of radiotherapy and surgery in the treatment of head and neck cancers .", "label": "", "metadata": {}, "score": "60.10353"}
{"text": "RT 1995 - 1997 62.5/25 split course with 1 week break ; 1997 - 2001 68/34 primary and 66/33 neck .If parapharyngeal extension or residual disease , 10 Gy boost .", "label": "", "metadata": {}, "score": "60.252476"}
{"text": "RT 1995 - 1997 62.5/25 split course with 1 week break ; 1997 - 2001 68/34 primary and 66/33 neck .If parapharyngeal extension or residual disease , 10 Gy boost .", "label": "", "metadata": {}, "score": "60.252476"}
{"text": "( Ma J , J Clin Oncol .2001 Mar 1;19(5):1350 - 7 . )Conclusion : No survival benefit for induction chemotherapy .Hokkaido RTOG ( 1991 - 1998 ) -- cisplatin , 5-FU .", "label": "", "metadata": {}, "score": "60.295364"}
{"text": "2006 Jan 1;64(1):47 - 56 . ) 8 trials , 1753 patients ( concurrent : INT 0099 , PWH - QEH Hong Kong , QMH Hong Kong , induction : PWH Hong Kong , AOCOA , VUMCA , Hokkaido , adjuvant : Taiwan ) .", "label": "", "metadata": {}, "score": "60.684"}
{"text": "Results .Forty - eight patients were included in the present analysis .Thirty - three were treated from the year 2000 onward .Median follow - up was 42 months ( range 17 - 144 ) .", "label": "", "metadata": {}, "score": "61.174664"}
{"text": "Conclusion : Preliminary , concurrent chemo with accelerated fractionation could significantly improve local tumor control .Hong Kong NPC-9901 ( N - disease ) ( 1999 - 2004 ) .", "label": "", "metadata": {}, "score": "61.2445"}
{"text": "2002 Apr 15;94(8):2217 - 23 . )Median F / U 4.1 years .Outcome : 5-year OS induction chemo 60 % vs. RT alone 48 % ( NS ) ; DFS 55 % vs. 43 % ( NS ) .", "label": "", "metadata": {}, "score": "61.37375"}
{"text": "Patients .Previous oral cavity cancer with or without treatment .Refusal of prescribed treatment .Treatment with palliative intent .Patients with tumors down - staged to Stage I or II from Stage III or IV on pathology .", "label": "", "metadata": {}, "score": "62.037407"}
{"text": "2005 Oct 1;23(28):6966 - 75 . )Median F / U 2.3 years .Outcome : DFS chemo - RT 72 % vs. RT alone 62 % ( SS ) , LRC 92 % vs. 82 % ( SS ) , DM 76 % vs. 73 % ( NS ) , OS 78 % vs. 78 % ( NS ) .", "label": "", "metadata": {}, "score": "62.106148"}
{"text": "Cunningham D , Allum WH , Stenning SP , et al .: Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer .N Engl J Med 2006 , 355 : 11 - 20 .", "label": "", "metadata": {}, "score": "62.427624"}
{"text": "Keywords .Gastric cancer Chemoradiotherapy Neoadjuvant .Introduction .Postoperative chemoradiotherapy ( CRT ) , perioperative chemotherapy ( ChT ) or postoperative ChT are the current standards of care for resectable gastric cancer based on the outcomes of phase III randomized trials [ 1 - 4 ] .", "label": "", "metadata": {}, "score": "62.469887"}
{"text": "Int J Radiat Oncol Biol Phys 1990 , 19 : 1357 - 1362 .PubMed View Article .Papachristou DN , Fortner JG : Local recurrence of gastric adenocarcinomas after gastrectomy .", "label": "", "metadata": {}, "score": "62.618973"}
{"text": "Preoperative CRT has several potential biological and technical advantages .The presence of intact tumor vasculature and oxygenation may enhance responsiveness to radiotherapy ( RT ) and systemic therapy .", "label": "", "metadata": {}, "score": "62.63546"}
{"text": "Retrospective .16 patients with NPC .Initial treatment 50 - 88 Gy ( 1 postop RT 50 Gy , 16 primary 65 - 88 Gy ) .", "label": "", "metadata": {}, "score": "62.82939"}
{"text": "Background .Cervical cancers that are bulky , extend to parametrial / pelvic tissues and/or involve pelvic lymph nodes benefit from external - beam plus intracavitary radiation .", "label": "", "metadata": {}, "score": "63.220848"}
{"text": "Comment : more patients at low risk for distant failure ; less active chemo combination .Queen Mary Hospital ; 2006 ( Hong Kong)(2000 - 2004 ) PMID 16213105 -- \" Preliminary results of radiation dose escalation for locally advanced nasopharyngeal carcinoma . \"", "label": "", "metadata": {}, "score": "63.407555"}
{"text": "Retrospective .11 patients .Recurrent NPC , with base of skull invasion , CN deficit 64 % .Heavy charged particles .Initial treatment median 70.2 Gy ( 61 - 81 Gy ) .", "label": "", "metadata": {}, "score": "63.45655"}
{"text": "PubMed .Forastiere AA , Goepfert H , Maor M : Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer .N Engl J Med .", "label": "", "metadata": {}, "score": "63.499714"}
{"text": "( Chua DT , Cancer .1998 Dec 1;83(11):2270 - 83 . )Median F / U 2.5 years .Outcome : 3-year RFS induction chemo 48 % vs. RT 42 % ( NS ) ; OS 78 % vs. 71 % ( NS ) .", "label": "", "metadata": {}, "score": "63.624992"}
{"text": "Preoperative CRT may also allow design of smaller and more accurate radiation treatment fields which could improve treatment tolerance , as well as identify patients with biologically aggressive disease in whom surgery should be avoided .", "label": "", "metadata": {}, "score": "63.643337"}
{"text": "Despite the negative results in prior studies , studies are investigating the use of consolidation with different chemotherapy agents , given the strong need to improve distant failure and overall survival rates .", "label": "", "metadata": {}, "score": "63.720367"}
{"text": "Brachytherapy boost .Long Beach Memorial Hospital ; 2000 ( 1978 - 97 ) PMID 10889385 -- \" Brachytherapy for primary and recurrent nasopharyngeal carcinoma : 20 years ' experience at Long Beach Memorial . \"", "label": "", "metadata": {}, "score": "63.80227"}
{"text": "( Brown AP , Int J Radiat Oncol Biol Phys . 1989 Jun;16(6):1607 - 14 . )Treatment planning .Proton vs photon comparison .Outcome : Proton superior dose - distribution , increase 5 Gy in median tumor dose , substantial reduction in normal tissue dose .", "label": "", "metadata": {}, "score": "63.818275"}
{"text": "Br J Cancer 2011 , 104 : 1840 - 1847 .PubMed View Article .Diaz - Gonzalez JA , Rodriguez J , Hernandez - Lizoain JL , et al .", "label": "", "metadata": {}, "score": "63.870354"}
{"text": "Burke EC , Karpeh MS , Conlon KC , et al .: Laparoscopy in the management of gastric adenocarcinoma .Ann Surg 1997 , 225 : 262 - 267 .", "label": "", "metadata": {}, "score": "63.952766"}
{"text": "348 patients , WHO grade II - III , T1 - 4N2-N3 ( AJCC-5)(key problem distant failure ; see companion trial NPC-9902 ) .", "label": "", "metadata": {}, "score": "64.12471"}
{"text": "Two patients ( 6 % ) died within 30 days following surgery .One died due to gastrointestinal hemorrhage and the other died from postoperative sepsis .", "label": "", "metadata": {}, "score": "64.55027"}
{"text": "Three - year actuarial LC and DFS rates for the entire cohort at 3 years were 72 % ( 95 % CI 55 - 90 ) and 30 % ( 95 % CI 17 - 44 ) , respectively .", "label": "", "metadata": {}, "score": "64.64706"}
{"text": "Br J Cancer 1989 , 60 : 739 - 744 .PubMed View Article .Zhang ZX , Gu XZ , Yin WB , et al .", "label": "", "metadata": {}, "score": "64.76962"}
{"text": "This presentation reports an update of RTOG 90 - 01 and denotes the toxicity data not evaluable at the first publication .Materials and Methods .", "label": "", "metadata": {}, "score": "64.94903"}
{"text": "CT - based treatment planning .Fields : included 2 cm margin on gross disease and included entire base of skull and sphenoid sinus , 2 cm posterior to mastoid process ; anteriorly included posterior 1/3 of maxillary sinus and nasal cavity .", "label": "", "metadata": {}, "score": "64.966606"}
{"text": "PubMed View Article .Atkins BZ , Shah AS , Hutcheson KA , et al .: Reducing hospital morbidity and mortality following esophagectomy .Ann Thorac Surg 2004 , 78 : 1170 - 1176 . discussion 1170 - 6 PubMed View Article .", "label": "", "metadata": {}, "score": "65.23361"}
{"text": "Conclusion : Group 1 ( T1 - 2N0 - 1 ; all IIB ) relatively poor survival due to mets , improved with induction chemo .", "label": "", "metadata": {}, "score": "65.39929"}
{"text": "Table 4 lists toxicities at least 3 months following surgery .There was one late grade 5 event stemming from complications following gastric perforation occurring during CRT .", "label": "", "metadata": {}, "score": "65.62055"}
{"text": "Those who completed CRT but did not undergo surgery had a median OS of 6 months .Kaplan - Meier estimates for overall survival , disease - free survival and local control for patients undergoing surgery .", "label": "", "metadata": {}, "score": "65.660095"}
{"text": "Materials and Methods .From September 1997 to November 2002 , patients with Stage III / IV ( T3 - 4Nany and TanyN3 ) WHO grade II / III NPC with ECOG performance status 0 - 1 were enrolled .", "label": "", "metadata": {}, "score": "65.69136"}
{"text": "Materials and Methods .From September 1997 to November 2002 , patients with Stage III / IV ( T3 - 4Nany and TanyN3 ) WHO grade II / III NPC with ECOG performance status 0 - 1 were enrolled .", "label": "", "metadata": {}, "score": "65.69136"}
{"text": "PubMed View Article .Siewert JR , Bottcher K , Stein HJ , et al .: Relevant prognostic factors in gastric cancer : ten - year results of the german gastric cancer study .", "label": "", "metadata": {}, "score": "65.77639"}
{"text": "Abbreviations : S - CRT , Surgery with adjuvant chemo - radiation therapy ; S - RT , Surgery with adjuvant radiation therapy ; CRT , Primary chemo - radiation therapy ; RT , Primary radiation therapy ; no . , Number .", "label": "", "metadata": {}, "score": "65.897385"}
{"text": "The data related to patterns of failure of quality of life were not available for presentation .The accrual goal of this study was 282 patients .", "label": "", "metadata": {}, "score": "65.936295"}
{"text": "Closed early due to slow accrual .189 patients , WHO grade II - III , Stage T3 - 4N0 - 1 ( AJCC-5)(key problem locoregional failure ; see companion trial NPC-9901 ) .", "label": "", "metadata": {}, "score": "66.027275"}
{"text": "Surgical resection typically occurred 4 - 6 weeks after CRT completion .The type of surgery depended upon the treating surgeon 's preference , primary tumor location and disease extent .", "label": "", "metadata": {}, "score": "66.12733"}
{"text": "10.1016/j.oraloncology.2011.07.018 .PubMed View Article .Chen AY , Fedewa S , Pavluck A : Improved survival is associated with treatment at high - volume teaching facilities for patients with advanced stage laryngeal cancer .", "label": "", "metadata": {}, "score": "66.60057"}
{"text": "The study accrual goal was 200 patients to achieve this power .Results .221 patients were enrolled , 3 of these patient were excluded .", "label": "", "metadata": {}, "score": "66.69269"}
{"text": "The study accrual goal was 200 patients to achieve this power .Results .221 patients were enrolled , 3 of these patient were excluded .", "label": "", "metadata": {}, "score": "66.69269"}
{"text": "The primary treatment modality for patients with localized gastric cancer is surgery .However , rates of both local and distant recurrence remain high following curative intent resection alone [ 20 - 23 ] .", "label": "", "metadata": {}, "score": "67.01073"}
{"text": "10.1001/archotol.1981.00790480001001 .PubMed View Article .Kramer S , Gelber RD , Snow JB : Combined radiation therapy and surgery in the management of head and neck cancer : final report of study 73 - 03 of the radiation therapy oncology group .", "label": "", "metadata": {}, "score": "67.116554"}
{"text": "The ACR is operated by Alberta Health Services Cancer Care and follows patients longitudinally and prospectively [ 15 ] .Demographic , survival and pathologic data were extracted from the ACR database .", "label": "", "metadata": {}, "score": "67.19333"}
{"text": "Because of this , these variables were accounted for in a multivariate Cox - regression analysis .Age adjusted CCI was also included in the multivariate analysis as age and co - morbidities have been shown to affect risk of mortality [ 16 ] .", "label": "", "metadata": {}, "score": "67.257385"}
{"text": "Guangzhou ( 1993 - 1994 ) - cisplatin , 5-FU , bleomycin .Randomized .456 patients .Chinese stage III - IV M0 .", "label": "", "metadata": {}, "score": "67.32063"}
{"text": "There were gains in Stage III - IVA disease , though the greatest advantage was seen in patients with Stage I - II disease .The benefit observed was gained without an increase in toxicity .", "label": "", "metadata": {}, "score": "67.538414"}
{"text": "There were gains in Stage III - IVA disease , though the greatest advantage was seen in patients with Stage I - II disease .The benefit observed was gained without an increase in toxicity .", "label": "", "metadata": {}, "score": "67.538414"}
{"text": "Am J Clin Oncol .2002 Jun;25(3):219 - 23 . ) 6 trials , 1528 patients ( concurrent : INT 0099 ; induction : Hong Kong , Guangzhou , AOCOA , VUMCA ; adjuvant : Italian ) .", "label": "", "metadata": {}, "score": "67.762024"}
{"text": "10.1056/NEJM199806183382503 .PubMed View Article .Charlson M , Szatrowski TP , Peterson J , Gold J : Validation of a combined comorbidity index .", "label": "", "metadata": {}, "score": "67.802666"}
{"text": "The radiation therapy delivered in this study was superior to previous regimens reported in that the median dose was higher and the median duration of treatment was shorter .", "label": "", "metadata": {}, "score": "67.883675"}
{"text": "The radiation therapy delivered in this study was superior to previous regimens reported in that the median dose was higher and the median duration of treatment was shorter .", "label": "", "metadata": {}, "score": "67.883675"}
{"text": "Randomized , 2x2 design ( concurrent chemo vs. none , adjuvant chemo vs. none ) .Arm 1 ) RT alone vs. Arm 2 ) concurrent chemo - RT vs. Arm 3 ) RT + adjuvant chemo vs. Arm 4 ) concurrent chemo - RT + adjuvant RT .", "label": "", "metadata": {}, "score": "68.02097"}
{"text": "Arm 1 had a higher rate of T2 tumors while Arm 2 had a higher rate of T1 and T4 tumors , although these were not statistically significant .", "label": "", "metadata": {}, "score": "68.07097"}
{"text": "Arm 1 had a higher rate of T2 tumors while Arm 2 had a higher rate of T1 and T4 tumors , although these were not statistically significant .", "label": "", "metadata": {}, "score": "68.07097"}
{"text": "All external - beam radiotherapy was delivered with megavoltage equipment .Patients were stratified by FIGO stage ( IB - IIB vs. III - IVA ) and method of PALN assessment .", "label": "", "metadata": {}, "score": "68.19891"}
{"text": "All external - beam radiotherapy was delivered with megavoltage equipment .Patients were stratified by FIGO stage ( IB - IIB vs. III - IVA ) and method of PALN assessment .", "label": "", "metadata": {}, "score": "68.19891"}
{"text": "Salvage surgical resection was offered to all patients with failed induction RT and CRT treatments .Statistical analysis .Baseline characteristics were compared using standard modes of comparison between multiple groups .", "label": "", "metadata": {}, "score": "68.29049"}
{"text": "Patients with adverse features of ECS , LVI , and PNI are at particular risk of disease progression and higher death rates [ 23 ] .", "label": "", "metadata": {}, "score": "68.35006"}
{"text": "Distant recurrence was defined as any recurrence outside the aforementioned sites .A consensus opinion was reached by two authors ( J.P. and B.C. ) on all suspected cases of local and distant recurrences as a means to improve accuracy .", "label": "", "metadata": {}, "score": "68.53592"}
{"text": "Table 2 .Thirty - six patients ( 75 % ) underwent surgery .Total gastrectomy was performed in 13 patients , partial gastrectomy in 9 patients and esophagogastrectomy in 14 patients ( Table 2 ) .", "label": "", "metadata": {}, "score": "68.831276"}
{"text": "2006 Sep 1;66(1):142 - 51 . )Median F / U 2.9 years .Outcome : 3-year FFS RT 70 % , AFRT 63 % , chemo - RT 74 % , chemo - AFRT 94 % ( SS ) .", "label": "", "metadata": {}, "score": "68.86624"}
{"text": "Tumor downstaging was defined as a decrease in either T stage and/or N stage at the time of resection .Patterns of failure were determined by imaging studies and/or by findings obtained from diagnostic procedures such as laparoscopy , laparotomy or computed tomography ( CT)-guided biopsies .", "label": "", "metadata": {}, "score": "69.108185"}
{"text": "Piessen G , Messager M , Leteurtre E , et al .: Signet ring cell histology is an independent predictor of poor prognosis in gastric adenocarcinoma regardless of tumoral clinical presentation .", "label": "", "metadata": {}, "score": "69.157524"}
{"text": "Loma Linda ; 1999 ( 1991 - 1997 )PMID 10551231 -- \" Nasopharyngeal carcinoma : repeat treatment with conformal proton therapy -- dose - volume histogram analysis . \"", "label": "", "metadata": {}, "score": "69.16347"}
{"text": "( Hui EP , J Clin Oncol .2009 Jan 10;27(2):242 - 9 .Epub 2008 Dec 8 . )Randomized Phase II .65 patients , Stage III - IVB NPC .", "label": "", "metadata": {}, "score": "69.1752"}
{"text": "Outcome : Prescribed IMRT given to 84 % ; prescribed chemo 65 % .2-year LC 93 % , LRC 89 % , DMFR 85 % .", "label": "", "metadata": {}, "score": "69.21559"}
{"text": "5-year LRF RT 28 % vs RT + rAd - p53 3 % ( SS ) ; 5-year DFS 57 % vs. 67 % ( NS ) ; 5-year OS 59 % vs. 67 % ( NS ) .", "label": "", "metadata": {}, "score": "69.384674"}
{"text": "Pelvic Radiation with Concurrent Chemotherapy Compared with Pelvic and Para - Aortic Radiation for High - Risk Cervical Cancer .Reviewer : Roberto J. Santiago , MD The Abramson Cancer Center of the University of Pennsylvania Last Modified : May 16 , 2003 .", "label": "", "metadata": {}, "score": "69.387634"}
{"text": "Group 1 ( T1 - 2N0 - 1 , was entirely IIB ) vs. Group 2 ( T1 - 2N2 - 3 ) vs. Group 3 ( T3 - 4N0 - 1 ) vs. Group 4 ( T3 - 4N2 - 3 ) .", "label": "", "metadata": {}, "score": "69.557755"}
{"text": "Conclusion : Preliminary , significant benefit for tumor control at the cost of higher toxicity .No early OS benefit .Singapore SQNP01 ( 1997 - 2003 ) .", "label": "", "metadata": {}, "score": "69.56716"}
{"text": "Median F / U 2.4 years .Outcome : 2-year DFS chemo - RT 68 % vs. RT alone 72 % ( NS ) ; OS 80 % vs. 80 % ( NS ) ; no difference in LRC , DM , or time - to - relapse .", "label": "", "metadata": {}, "score": "69.68323"}
{"text": "The 3-year OS rate for patients who underwent surgery was 50 % ( 95 % CI 33 - 68 ) ( Figure 2 ) .", "label": "", "metadata": {}, "score": "70.0567"}
{"text": "Data collection .Cancer surveillance data was retrieved by a clinical data analyst from Alberta Health Services .Data for all patients diagnosed with OCSCC in Alberta between January 1 , 1998 and January 1 , 2010 were obtained from the Alberta Cancer Registry ( ACR ) .", "label": "", "metadata": {}, "score": "70.2354"}
{"text": "( Chua DT , Int J Radiat Oncol Biol Phys .2006 Aug 1;65(5):1300 - 6 .Epub 2006 Jun 5 . )Subset analysis .", "label": "", "metadata": {}, "score": "70.318054"}
{"text": "OS 83 % , 73 % , 87 % , 88 % ( NS ) .Toxicity Grade 3 - 5 : Acute : RT 55 % , AFRT 70 % , chemo - RT 83 % , chemo - AFRT 86 % ( concurrent chemo SS worse ) .", "label": "", "metadata": {}, "score": "70.42179"}
{"text": "This study was approved by the University of Alberta 's Health Research Ethics Board .Consent .Written informed consent was obtained from the patient for publication of this report and any accompanying images .", "label": "", "metadata": {}, "score": "70.770874"}
{"text": "2005 Apr 6;97(7):536 - 9 . )Median F / U 5.5 years .Subgroup analysis no benefit for T1 - 2 , but benefit for T3 - 4 ( HR 0.51 ) .", "label": "", "metadata": {}, "score": "71.01327"}
{"text": "Median follow up is now 4.6 years , and 6.6 years in the survivors .Results .Outcomes were better for patients treated with chemoradiation .", "label": "", "metadata": {}, "score": "71.87958"}
{"text": "Median follow up is now 4.6 years , and 6.6 years in the survivors .Results .Outcomes were better for patients treated with chemoradiation .", "label": "", "metadata": {}, "score": "71.87958"}
{"text": "1186/\u200b1916 - 0216 - 42 - 30 ) contains supplementary material , which is available to authorized users .Introduction .The oral cavity is the most common site for head and neck squamous cell carcinoma .", "label": "", "metadata": {}, "score": "71.97007"}
{"text": "Outcome : 3-year OS was 93 % and DFS was 65 % ; both substantially better than historical controls .Conclusion : INT 0099 regimen should be standard of care .", "label": "", "metadata": {}, "score": "71.985565"}
{"text": "Demographic , pathologic , treatment , and survival data was obtained from patients diagnosed with OCSCC from 1998 - 2010 in Alberta , Canada .222 patients were included in the final analysis from 895 OCSCC patients .", "label": "", "metadata": {}, "score": "72.04216"}
{"text": "10.1002/hed.2890100105 .PubMed View Article .Snow GB , Annyas AA , van Slooten EA , Bartelink H : Prognostic factors of neck node metastasis .", "label": "", "metadata": {}, "score": "72.38876"}
{"text": "Patients were grouped by treatment .Analyses were performed with SPSS Statistics 19.0 ( SPSS Inc , Chicago , IL ) .Results .Patient population .", "label": "", "metadata": {}, "score": "72.39505"}
{"text": "10.1111/j.1365 - 2273.1982.tb01581.x .PubMed View Article .Vikram B , Strong E , Shah JP : Failure at the primary site following multimodality treatment in advanced head and neck cancer .", "label": "", "metadata": {}, "score": "72.73341"}
{"text": "10.1002/hed.20279 .PubMed View Article .Szklo M : Population - based cohort studies .Epidemiol Rev. 1998 , 20 : 81 - 90 .", "label": "", "metadata": {}, "score": "72.76864"}
{"text": "Methods .Ethics approval for the study was granted by the University of Alberta 's Health Research Ethics Board ( HREB ) and the Alberta Cancer Board .", "label": "", "metadata": {}, "score": "72.95654"}
{"text": ": Cancer of the stomach .A patient care study by the American College of Surgeons .Ann Surg 1993 , 218 : 583 - 592 .", "label": "", "metadata": {}, "score": "72.99063"}
{"text": "J Clin Oncol 2004 , 22 : 2774 - 2780 .PubMed View Article .Reed VK , Krishnan S , Mansfield PF , et al .", "label": "", "metadata": {}, "score": "73.346054"}
{"text": "Therefore , perhaps cisplatin + 5-FU is better than cisplatin alone .However , weekly cisplatin has advantages as well , mainly in the ability to dose adjust more quickly if toxicity arises .", "label": "", "metadata": {}, "score": "73.43829"}
{"text": "Therefore , perhaps cisplatin + 5-FU is better than cisplatin alone .However , weekly cisplatin has advantages as well , mainly in the ability to dose adjust more quickly if toxicity arises .", "label": "", "metadata": {}, "score": "73.43829"}
{"text": "Median retreatment dose 50 GyE ( 32 - 62 ) .Outcome : LC 45 % .5-year OS 31 % .Conclusion : Results appear superior to others using conventional photon therapy .", "label": "", "metadata": {}, "score": "73.627625"}
{"text": "J Clin Oncol 2006 , 24 : 3953 - 3958 .PubMed View Article .Ajani JA , Mansfield PF , Crane CH , et al .", "label": "", "metadata": {}, "score": "73.72503"}
{"text": "Toxicity was graded according to the Common Toxicity Criteria for Adverse Events version 4.0 .Results .Forty - eight patients were included .Most ( 73 % ) had proximal ( GE junction , cardia and fundus ) tumors .", "label": "", "metadata": {}, "score": "73.9166"}
{"text": "J Clin Oncol 2005 , 23 : 1237 - 1244 .PubMed View Article .Ajani JA , Mansfield PF , Janjan N , et al .", "label": "", "metadata": {}, "score": "73.92088"}
{"text": "References .Fletcher GH , Evers W : Radiotherapeutic management of surgical recurrences and postoperative residuals in tumors of the head and neck .Radiology .", "label": "", "metadata": {}, "score": "74.07022"}
{"text": "Categorical data was compared using the chi - squared test .Overall , disease - specific , disease - free and metastases - free survival analyses were performed using Kaplan - Meier analyses to determine year - specific estimated actuarial survival rates .", "label": "", "metadata": {}, "score": "74.10655"}
{"text": "RCTs typically have stringent enrolment criteria and as a result , physicians must be careful in applying results to their practice .The effects of these studies are then important to be examined on the population they are applied to .", "label": "", "metadata": {}, "score": "74.45332"}
{"text": "Background .The oral cavity is the most common site for head and neck squamous cell carcinoma .Treatment of advanced stage oral cavity squamous cell carcinoma ( OCSCC ) has classically involved surgical resection with postoperative adjuvant radiotherapy ( S - RT ) .", "label": "", "metadata": {}, "score": "74.63431"}
{"text": "Outcome : 3-year PFS neoadjuvant 88 % vs control 59 % ( HR 0.49 , NS ) , 3-year OS 94 % vs 68 % ( HR 0.24 , SS ) .", "label": "", "metadata": {}, "score": "74.85687"}
{"text": "Prince of Wales Hospital PWH-88 , Hong Kong ( 1988 - 1991 ) -- cisplatin , 5-FU .Randomized .82 patients .Arm 1 ) Neoadjuvant cisplatin 100 mg / m2 + 5-FU 1000 mg / m2 , 4 weeks later RT 66 Gy with lower neck to 58 Gy , then 4 cycles of adjuvant chemo vs. Arm 2 ) RT alone .", "label": "", "metadata": {}, "score": "74.90713"}
{"text": "Outcome : Conformality ratio for photon / proton plan 3.1 vs. photons only 5.7 for CTV1 , no difference for CTV2 .Normal tissues favored photon / proton plan .", "label": "", "metadata": {}, "score": "75.29198"}
{"text": "( No Authors , Int J Radiat Oncol Biol Phys .1996 Jun 1;35(3):463 - 9 . )Median F / U 4.1 years .No difference in OS .", "label": "", "metadata": {}, "score": "75.42601"}
{"text": "While the number of events are small , our data suggest that both local and distant recurrences are still problematic despite aggressive combined modality therapy .", "label": "", "metadata": {}, "score": "75.9273"}
{"text": "The age adjusted CCI used in this study accounts for both age and comorbidity as a predictor of death from comorbid disease .Survival analysis .", "label": "", "metadata": {}, "score": "76.04098"}
{"text": "Advanced stage OCSCC remains a challenging disease to treat .For many years , primary ablative surgery followed by postoperative radiotherapy was the standard of care .", "label": "", "metadata": {}, "score": "76.048355"}
{"text": "Int J Radiat Oncol Biol Phys 1982 , 8 : 1 - 11 .PubMed View Article .Landry J , Tepper JE , Wood WC , et al .", "label": "", "metadata": {}, "score": "76.057144"}
{"text": "2004 Sep 1;60(1):156 - 64 . )Original ( AJCC 1992 ) stage : Stage III 20 % , Stage IV 80 % .Restaged ( AJCC 1997 ) : Stage II / III 71 % , Stage IV 29 % .", "label": "", "metadata": {}, "score": "76.15231"}
{"text": "Int J Radiat Oncol Biol Phys 2008 , 71 : 741 - 747 .PubMed View Article .Fields RC , Strong VE , Gonen M , et al .", "label": "", "metadata": {}, "score": "76.35419"}
{"text": "Int J Radiat Oncol Biol Phys 1998 , 42 : 929 - 934 .PubMed View Article .Ajani JA , Winter K , Okawara GS , et al .", "label": "", "metadata": {}, "score": "76.9937"}
{"text": "Thus , if patients died without any evidence of disease , they were considered disease free at the time of death .Metastasis - free survival was defined as the time from the first day of treatment to the date of distant metastasis detection .", "label": "", "metadata": {}, "score": "77.0258"}
{"text": "Disease - specific survival was defined as the time from the first day of treatment to death as a result of the disease .Death caused by the primary cancer was therefore considered to be disease specific death .", "label": "", "metadata": {}, "score": "77.49928"}
{"text": "( Pan JJ , J Clin Oncol .2008 Dec 22 .[ Epub ahead of print ] )Median F / U 5.1 years .", "label": "", "metadata": {}, "score": "77.75166"}
{"text": "Future studies should focus on improving this rate , particularly with respect to the distant metastatic rate , as well as decreasing toxicity from treatment .", "label": "", "metadata": {}, "score": "78.22797"}
{"text": "Future studies should focus on improving this rate , particularly with respect to the distant metastatic rate , as well as decreasing toxicity from treatment .", "label": "", "metadata": {}, "score": "78.227974"}
{"text": "PubMed View Article .Horn RC Jr : Carcinoma of the stomach ; autopsy findings in untreated cases .Gastroenterology 29 : 515 - 523 . discussion , 523 - 5 , 1955 .", "label": "", "metadata": {}, "score": "78.24324"}
{"text": "In addition , RT techniques differ in Asia compared to other parts of the world , and the RT only arm of Intergroup Trail 0099 appeared to be lower than is usually seen Asia .", "label": "", "metadata": {}, "score": "78.783295"}
{"text": "In addition , RT techniques differ in Asia compared to other parts of the world , and the RT only arm of Intergroup Trail 0099 appeared to be lower than is usually seen Asia .", "label": "", "metadata": {}, "score": "78.783295"}
{"text": "Taiwan ( 1993 - 1999 ) .Randomized .284 patients , NPC Stage III - IV M0 , histology WHO I ( 3 % ) , WHO II ( 73 % ) , WHO III ( 24 % ) .", "label": "", "metadata": {}, "score": "80.24441"}
{"text": "An age adjusted comorbidity score of 2 was associated with a 2.10 estimated relative risk while a score of 8 or higher was conferred to have a 19.37 estimated relative risk [ 16 ] .", "label": "", "metadata": {}, "score": "81.22548"}
{"text": "This was calculated as the time from the first date of treatment to the date of death or last known date the patient was alive .", "label": "", "metadata": {}, "score": "81.299324"}
{"text": "Presenter : Patricia Eifel Presenter 's Affiliation : RTOG Type of Session : Plenary .Background .There have been several studies documenting the efficacy of chemoradiation over radiation alone in the treatment of locally advanced cervical cancer .", "label": "", "metadata": {}, "score": "81.30612"}
{"text": "Median F / U 6 years .Outcome : Addition of chemo absolute survival benefit of 6 % at 5 years ( 56 % to 62 % ) , absolute EFS benefit of 10 % ( 42 % to 52 % ) .", "label": "", "metadata": {}, "score": "81.33436"}
{"text": "Toxicity : Acute Grade 4 mucositis 4 % ; Late Grade 3 dysphagia 5 % , xerostomia 3 % .Long - term PEG - dependent 4 % .", "label": "", "metadata": {}, "score": "81.78732"}
{"text": "Mean F / U 2 years .Outcome : 2-year LRFS 50 % , OS 50 % .By DVH coverage \" optimal \" 83 % vs \" suboptimal \" 17 % ( SS ) .", "label": "", "metadata": {}, "score": "81.840775"}
{"text": "( Cooper JS et al .Int J Radiat Oncol Biol Phys . 2000 Jul 1;47(4):861 - 6 . )Retrospective single institution .Repeated regimen of Intergroup 0099 .", "label": "", "metadata": {}, "score": "83.015755"}
{"text": "Nasopharyngeal cancer ( NPC ) is most prevalent in Asia and in these endemic areas , the types of NPC differ from those seen in other parts of the world .", "label": "", "metadata": {}, "score": "83.80806"}
{"text": "PubMed View Article .Edge SB : AJCC cancer staging handbook : from the AJCC cancer staging manual .2010 , New York : Springer , 7 .", "label": "", "metadata": {}, "score": "84.4603"}
{"text": "Presented at the 52th Annual Meeting of the American Society of Radiation Oncology , San Diego , California , October 31-November 4 , 2010 .", "label": "", "metadata": {}, "score": "85.16913"}
{"text": "PALN irradiation is probably necessary for patients with known para - aortic involvement , and may benefit selected patients when used in a prophylactic setting .", "label": "", "metadata": {}, "score": "85.19953"}
{"text": "PALN irradiation is probably necessary for patients with known para - aortic involvement , and may benefit selected patients when used in a prophylactic setting .", "label": "", "metadata": {}, "score": "85.19953"}
{"text": "Outcome : DFS / PFS improved 2 years 37 % , 3 years 40 % , 4 years 34 % .OS improved 2 years 20 % ( NS ) , 3 years 19 % ( NS ) , 4 years 21 % ( SS ) .", "label": "", "metadata": {}, "score": "85.53501"}
{"text": "Age adjusted Charlson Comorbidity Index ( CCI ) scores [ 16 ] , which were not included in the ACR database , were calculated using relevant comorbidities taken from chart review .", "label": "", "metadata": {}, "score": "85.62704"}
{"text": "10.1016/S0305 - 7372(75)80002 - 8 .PubMed View Article .Szpirglas H , Chastang CL , Bertrand JC : Adjuvant treatment of tongue and floor of the mouth cancer .", "label": "", "metadata": {}, "score": "85.65181"}
{"text": "Also significant hematologic toxicity .Conclusion : Confirmation of INT 0099 results ; also applicable in endemic NPC .Queen Mary Hospital , Hong Kong ( 1995 - 2001 ) .", "label": "", "metadata": {}, "score": "85.94575"}
{"text": "Arm 1 ) RT alone vs. Arm 2 ) concurrent chemo - RT vs. Arm 3 ) RT + adjuvant chemo vs. Arm 4 ) concurrent chemo - RT + adjuvant RT .", "label": "", "metadata": {}, "score": "86.59196"}
{"text": "( Wu SX , Int J Radiat Oncol Biol Phys .2007 Nov 1;69(3):761 - 9 . )Retrospective .Median dose 18/3 or 48/6 .", "label": "", "metadata": {}, "score": "86.924255"}
{"text": "The primary endpoint was progression - free survival ( PFS ) .Secondary endpoints were response rate , overall survival ( OS ) , safety profile , and quality of life .", "label": "", "metadata": {}, "score": "87.80025"}
{"text": "Toxicity was assigned using the National Cancer Institute Common Toxicity Criteria for Adverse Events version 4.0 ( CTCAE v4.0 ) .Acute toxicity was defined as any toxicity from the start of preoperative therapy until surgery .", "label": "", "metadata": {}, "score": "88.36505"}
{"text": "Below are the links to the authors ' original submitted files for images .Competing interest .The authors declare that they have no competing interest .", "label": "", "metadata": {}, "score": "88.70414"}
{"text": "HS is the senior author and was involved in all levels of study design , data analysis and manuscript preption .The manuscript was read and approved by all the authors .", "label": "", "metadata": {}, "score": "89.93336"}
{"text": "JP , BC , MP , CW and DT assisted in manuscript writing .All authors read and approved the final manuscript .Authors ' Affiliations .", "label": "", "metadata": {}, "score": "91.03298"}
{"text": "This material has never been published and is not currently under evaluation in any other peer - reviewed publication .Authors ' Affiliations .Division of Otolaryngology - Head and Neck Surgery , University of Alberta .", "label": "", "metadata": {}, "score": "91.166374"}
{"text": "Toxicity Grade 3 - 4 : stomatitis 29 % vs. 19 % , nausea 14 % vs. 5 % , leukopenia 23 % vs. 1 % .", "label": "", "metadata": {}, "score": "91.251175"}
{"text": "HZ is responsible for study design , statistical analysis , and manuscript preption .PD was responsible for statistical analysis and manuscript preption .VB was responsible for study design .", "label": "", "metadata": {}, "score": "91.71589"}
{"text": "Reviewer : Ryan Smith , MD OncoLink Last Modified : October 7 , 2002 .Presenter : Patricia Eifel Presenter 's Affiliation : RTOG Type of Session : Plenary .", "label": "", "metadata": {}, "score": "95.620346"}
{"text": "Reviewer : S. Jack Wei , MD Abramson Cancer Center of the University of Pennsylvania Last Modified : June 8 , 2004 .Presenter : Joseph Wee Presenter 's Affiliation : National Cancer Center , Singapore Type of Session : Scientific .", "label": "", "metadata": {}, "score": "96.46584"}
{"text": "Acknowledgment .NB : The corresponding author has full access to the data in this study and takes responsibility for the integrity of the data and accuracy of the data analysis .", "label": "", "metadata": {}, "score": "96.541245"}
{"text": "Presenter : Joseph Wee Presenter 's Affiliation : National Cancer Center , Singapore Type of Session : Scientific .Background .Nasopharyngeal cancer ( NPC ) is most prevalent in Asia and in these endemic areas , the types of NPC differ from those seen in other parts of the world .", "label": "", "metadata": {}, "score": "97.84563"}
{"text": "Annemarie Fernandes The Abramson Cancer Center of the University of Pennsylvania Last Modified : June 4 , 2012 .Presenter : Rudolf M. Huber , MD , PhD , FCCP Presenter 's Affiliation : Medizinische Klinik Innenstadt , M\u00fcnchen , Germany .", "label": "", "metadata": {}, "score": "100.6741"}
{"text": "CO;2 - 1 .PubMed View Article .Copyright .\u00a9 Zhang et al . ; licensee BioMed Central Ltd. 2013 .This article is published under license to BioMed Central Ltd.", "label": "", "metadata": {}, "score": "100.70099"}
{"text": "Competing interest .The authors declare that they have no competing interests .Authors ' contributions .JP and BC performed study conception and design .", "label": "", "metadata": {}, "score": "103.074326"}
{"text": "PubMed View Article .Copyright .\u00a9 Pepek et al . ; licensee BioMed Central Ltd. 2013 .This article is published under license to BioMed Central Ltd.", "label": "", "metadata": {}, "score": "108.366875"}
{"text": "Department of Surgery , Duke University School of Medicine .Department of Medicine , Division of Medical Oncology , Duke University School of Medicine .References .", "label": "", "metadata": {}, "score": "111.048836"}
{"text": "Blogs .", "label": "", "metadata": {}, "score": "122.62136"}
